Gene Symbol | Gene ID | Gene Info |
---|---|---|
Taf1
|
ENSMUSG00000031314.11 | TATA-box binding protein associated factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chrX_101532388_101532883 | Taf1 | 99 | 0.961899 | 0.72 | 6.3e-10 | Click! |
chrX_101532937_101533274 | Taf1 | 346 | 0.854839 | 0.51 | 6.5e-05 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr15_79690079_79691459 | 49.49 |
Gtpbp1 |
GTP binding protein 1 |
76 |
0.92 |
chr2_168206505_168207218 | 43.70 |
Adnp |
activity-dependent neuroprotective protein |
61 |
0.95 |
chr11_83224251_83224525 | 36.26 |
Gm11427 |
predicted gene 11427 |
66 |
0.72 |
chrX_51204673_51205680 | 31.40 |
Mbnl3 |
muscleblind like splicing factor 3 |
656 |
0.65 |
chr12_108794058_108794786 | 29.55 |
Yy1 |
YY1 transcription factor |
1449 |
0.23 |
chr15_81585272_81586453 | 23.80 |
Gm23880 |
predicted gene, 23880 |
271 |
0.52 |
chr4_130662932_130663461 | 23.09 |
Pum1 |
pumilio RNA-binding family member 1 |
125 |
0.97 |
chr4_127022250_127022463 | 22.99 |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
1027 |
0.39 |
chr2_153161013_153161878 | 22.16 |
Tm9sf4 |
transmembrane 9 superfamily protein member 4 |
96 |
0.96 |
chr11_103132227_103133103 | 21.45 |
Hexim2 |
hexamethylene bis-acetamide inducible 2 |
236 |
0.88 |
chrX_50611803_50612121 | 20.37 |
Firre |
functional intergenic repeating RNA element |
20003 |
0.24 |
chr12_51376987_51377614 | 19.94 |
Scfd1 |
Sec1 family domain containing 1 |
210 |
0.95 |
chr2_117122778_117122969 | 19.68 |
Spred1 |
sprouty protein with EVH-1 domain 1, related sequence |
1235 |
0.52 |
chr4_116075295_116075711 | 19.40 |
Lrrc41 |
leucine rich repeat containing 41 |
40 |
0.86 |
chr7_127512245_127512439 | 19.01 |
Srcap |
Snf2-related CREBBP activator protein |
41 |
0.86 |
chr2_27982205_27982376 | 18.43 |
Col5a1 |
collagen, type V, alpha 1 |
35151 |
0.16 |
chr13_111808856_111809050 | 18.31 |
Map3k1 |
mitogen-activated protein kinase kinase kinase 1 |
40 |
0.69 |
chr8_22859414_22859652 | 18.15 |
Kat6a |
K(lysine) acetyltransferase 6A |
2 |
0.97 |
chr7_111082142_111082831 | 18.12 |
Eif4g2 |
eukaryotic translation initiation factor 4, gamma 2 |
291 |
0.86 |
chrX_50614485_50614683 | 17.95 |
Firre |
functional intergenic repeating RNA element |
20482 |
0.24 |
chr2_28641046_28641358 | 17.79 |
Tsc1 |
TSC complex subunit 1 |
26 |
0.96 |
chr3_135440579_135440744 | 17.62 |
Ube2d3 |
ubiquitin-conjugating enzyme E2D 3 |
1450 |
0.23 |
chrY_1245411_1245577 | 17.10 |
Uty |
ubiquitously transcribed tetratricopeptide repeat gene, Y chromosome |
27 |
0.97 |
chr9_46012271_46012911 | 17.05 |
Pafah1b2 |
platelet-activating factor acetylhydrolase, isoform 1b, subunit 2 |
99 |
0.68 |
chr3_95624529_95625035 | 17.04 |
Ensa |
endosulfine alpha |
211 |
0.86 |
chr11_104441961_104442372 | 17.02 |
Kansl1 |
KAT8 regulatory NSL complex subunit 1 |
125 |
0.96 |
chr2_115581580_115581779 | 16.93 |
BC052040 |
cDNA sequence BC052040 |
37 |
0.61 |
chr4_120825669_120825856 | 16.88 |
Nfyc |
nuclear transcription factor-Y gamma |
55 |
0.96 |
chr15_102203424_102203965 | 16.81 |
Zfp740 |
zinc finger protein 740 |
3 |
0.49 |
chr6_31398589_31398905 | 16.77 |
Mkln1os |
muskelin 1, intracellular mediator containing kelch motifs, opposite strand |
6 |
0.5 |
chr11_62457273_62457444 | 16.77 |
Ncor1 |
nuclear receptor co-repressor 1 |
26 |
0.95 |
chr8_84839977_84840816 | 16.73 |
Rad23a |
RAD23 homolog A, nucleotide excision repair protein |
240 |
0.8 |
chr1_166002288_166003185 | 16.69 |
Pou2f1 |
POU domain, class 2, transcription factor 1 |
58 |
0.72 |
chr5_114380728_114380918 | 16.67 |
Ube3b |
ubiquitin protein ligase E3B |
3 |
0.82 |
chr16_22265059_22265533 | 16.65 |
Tra2b |
transformer 2 beta |
604 |
0.63 |
chr8_84832072_84832373 | 16.63 |
Dand5 |
DAN domain family member 5, BMP antagonist |
187 |
0.78 |
chr11_75733038_75733694 | 16.63 |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
218 |
0.92 |
chr1_152902262_152902717 | 16.57 |
Smg7 |
Smg-7 homolog, nonsense mediated mRNA decay factor (C. elegans) |
133 |
0.95 |
chrX_142966486_142967001 | 16.57 |
Ammecr1 |
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
15 |
0.98 |
chr7_44985781_44987176 | 16.21 |
Prmt1 |
protein arginine N-methyltransferase 1 |
14 |
0.83 |
chr11_106787265_106787858 | 16.19 |
Ddx5 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 5 |
906 |
0.34 |
chr12_111538536_111538865 | 16.09 |
Eif5 |
eukaryotic translation initiation factor 5 |
82 |
0.94 |
chrX_151520213_151521244 | 15.97 |
Phf8 |
PHD finger protein 8 |
56 |
0.97 |
chr8_84729971_84731532 | 15.91 |
G430095P16Rik |
RIKEN cDNA G430095P16 gene |
7744 |
0.11 |
chr15_80133018_80133226 | 15.71 |
Tab1 |
TGF-beta activated kinase 1/MAP3K7 binding protein 1 |
5 |
0.96 |
chrX_50602513_50602668 | 15.59 |
Firre |
functional intergenic repeating RNA element |
10631 |
0.26 |
chr11_85234370_85234971 | 15.50 |
Appbp2os |
amyloid beta precursor protein (cytoplasmic tail) binding protein 2, opposite strand |
105 |
0.84 |
chr8_105636501_105636656 | 15.11 |
Ctcf |
CCCTC-binding factor |
1 |
0.88 |
chr14_76520183_76520537 | 15.00 |
E130202H07Rik |
RIKEN cDNA E130202H07 gene |
6232 |
0.21 |
chr4_107066747_107067093 | 15.00 |
Mrpl37 |
mitochondrial ribosomal protein L37 |
52 |
0.51 |
chr6_92091630_92092420 | 14.95 |
Nr2c2 |
nuclear receptor subfamily 2, group C, member 2 |
408 |
0.83 |
chr1_105993664_105994496 | 14.84 |
Zcchc2 |
zinc finger, CCHC domain containing 2 |
3391 |
0.19 |
chr11_6546377_6546579 | 14.84 |
Gm24000 |
predicted gene, 24000 |
243 |
0.61 |
chr15_89211527_89212038 | 14.83 |
Ppp6r2 |
protein phosphatase 6, regulatory subunit 2 |
181 |
0.9 |
chr4_70409944_70410983 | 14.66 |
Cdk5rap2 |
CDK5 regulatory subunit associated protein 2 |
20 |
0.99 |
chr19_4397000_4397495 | 14.62 |
Kdm2a |
lysine (K)-specific demethylase 2A |
152 |
0.93 |
chr16_92825453_92825611 | 14.49 |
Runx1 |
runt related transcription factor 1 |
246 |
0.95 |
chr7_28338184_28338946 | 14.27 |
Supt5 |
suppressor of Ty 5, DSIF elongation factor subunit |
141 |
0.89 |
chr13_23550918_23551238 | 14.26 |
H4c6 |
H4 clustered histone 6 |
570 |
0.37 |
chr2_168154178_168154991 | 14.17 |
E130018N17Rik |
RIKEN cDNA E130018N17 gene |
71 |
0.93 |
chr5_3927786_3928551 | 14.13 |
Akap9 |
A kinase (PRKA) anchor protein (yotiao) 9 |
10 |
0.98 |
chr17_29032801_29033193 | 14.12 |
Srsf3 |
serine and arginine-rich splicing factor 3 |
308 |
0.54 |
chr3_65957517_65957709 | 13.97 |
Ccnl1 |
cyclin L1 |
40 |
0.63 |
chr19_47067510_47068274 | 13.94 |
Taf5 |
TATA-box binding protein associated factor 5 |
146 |
0.92 |
chr1_86160578_86160757 | 13.92 |
Armc9 |
armadillo repeat containing 9 |
5848 |
0.14 |
chr10_80755080_80755608 | 13.84 |
Dot1l |
DOT1-like, histone H3 methyltransferase (S. cerevisiae) |
119 |
0.91 |
chr6_13607973_13608602 | 13.77 |
Tmem168 |
transmembrane protein 168 |
187 |
0.96 |
chr2_119594112_119594386 | 13.74 |
Oip5os1 |
Opa interacting protein 5, opposite strand 1 |
48 |
0.96 |
chr11_103953918_103954240 | 13.73 |
Nsf |
N-ethylmaleimide sensitive fusion protein |
23 |
0.98 |
chr7_110061019_110061438 | 13.65 |
Zfp143 |
zinc finger protein 143 |
11 |
0.57 |
chrX_103493565_103494070 | 13.61 |
Jpx |
Jpx transcript, Xist activator (non-protein coding) |
22 |
0.94 |
chr2_128966994_128968230 | 13.56 |
Gm10762 |
predicted gene 10762 |
113 |
0.62 |
chr6_143099474_143100534 | 13.53 |
C2cd5 |
C2 calcium-dependent domain containing 5 |
1 |
0.97 |
chr13_96542688_96543170 | 13.48 |
Col4a3bp |
collagen, type IV, alpha 3 (Goodpasture antigen) binding protein |
174 |
0.65 |
chr5_23434241_23434661 | 13.25 |
Kmt2e |
lysine (K)-specific methyltransferase 2E |
2 |
0.7 |
chr6_33248856_33249174 | 13.10 |
Exoc4 |
exocyst complex component 4 |
70 |
0.95 |
chr10_80561468_80561652 | 13.08 |
Rexo1 |
REX1, RNA exonuclease 1 |
0 |
0.94 |
chr5_52782674_52783192 | 13.03 |
Zcchc4 |
zinc finger, CCHC domain containing 4 |
121 |
0.97 |
chr11_87756139_87756345 | 13.03 |
Mir142 |
microRNA 142 |
622 |
0.29 |
chr12_102787667_102787818 | 13.02 |
Gm47042 |
predicted gene, 47042 |
23030 |
0.08 |
chr11_120098578_120099000 | 12.98 |
Tepsin |
TEPSIN, adaptor related protein complex 4 accessory protein |
58 |
0.6 |
chr11_97315740_97315957 | 12.97 |
Mrpl45 |
mitochondrial ribosomal protein L45 |
60 |
0.96 |
chr4_154963939_154964275 | 12.92 |
Pank4 |
pantothenate kinase 4 |
16 |
0.96 |
chr14_21500430_21500993 | 12.88 |
Kat6b |
K(lysine) acetyltransferase 6B |
142 |
0.96 |
chr6_119175024_119175381 | 12.79 |
Dcp1b |
decapping mRNA 1B |
51 |
0.98 |
chr1_93478015_93478630 | 12.60 |
Hdlbp |
high density lipoprotein (HDL) binding protein |
55 |
0.91 |
chr19_7205794_7206453 | 12.52 |
Otub1 |
OTU domain, ubiquitin aldehyde binding 1 |
111 |
0.94 |
chr2_50296625_50296939 | 12.52 |
Mmadhc |
methylmalonic aciduria (cobalamin deficiency) cblD type, with homocystinuria |
19 |
0.5 |
chrX_85614215_85614411 | 12.48 |
Gm44378 |
predicted gene, 44378 |
25336 |
0.18 |
chr9_106170484_106171031 | 12.46 |
Wdr82 |
WD repeat domain containing 82 |
171 |
0.89 |
chr7_29180085_29180886 | 12.40 |
Psmd8 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 8 |
4 |
0.94 |
chr7_128740380_128740732 | 12.32 |
Mcmbp |
minichromosome maintenance complex binding protein |
61 |
0.94 |
chr9_62980541_62981320 | 12.27 |
Pias1 |
protein inhibitor of activated STAT 1 |
47 |
0.98 |
chr3_51978067_51978264 | 12.25 |
Gm20089 |
predicted gene, 20089 |
2776 |
0.18 |
chr6_39725249_39725946 | 12.23 |
Braf |
Braf transforming gene |
134 |
0.96 |
chr3_152396566_152396793 | 12.20 |
Zzz3 |
zinc finger, ZZ domain containing 3 |
5 |
0.96 |
chr3_88950688_88951221 | 12.08 |
Dap3 |
death associated protein 3 |
83 |
0.78 |
chr11_76763492_76763835 | 12.05 |
Gosr1 |
golgi SNAP receptor complex member 1 |
84 |
0.97 |
chr6_51469210_51469509 | 11.99 |
Hnrnpa2b1 |
heterogeneous nuclear ribonucleoprotein A2/B1 |
413 |
0.72 |
chr2_6322120_6322906 | 11.99 |
Usp6nl |
USP6 N-terminal like |
154 |
0.85 |
chrX_20662776_20662992 | 11.95 |
Uba1 |
ubiquitin-like modifier activating enzyme 1 |
14 |
0.97 |
chr5_135063982_135064334 | 11.93 |
Dnajc30 |
DnaJ heat shock protein family (Hsp40) member C30 |
44 |
0.51 |
chr17_24169345_24169534 | 11.93 |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
22 |
0.94 |
chr10_62792164_62792669 | 11.80 |
Ccar1 |
cell division cycle and apoptosis regulator 1 |
130 |
0.93 |
chr11_23306340_23306651 | 11.73 |
Usp34 |
ubiquitin specific peptidase 34 |
400 |
0.87 |
chr10_43791761_43792071 | 11.70 |
Gm9034 |
predicted pseudogene 9034 |
29315 |
0.12 |
chr2_49451967_49452295 | 11.60 |
Epc2 |
enhancer of polycomb homolog 2 |
645 |
0.79 |
chr3_95434194_95434904 | 11.59 |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
30 |
0.95 |
chr11_98192905_98193456 | 11.56 |
Med1 |
mediator complex subunit 1 |
80 |
0.95 |
chr11_96830373_96830568 | 11.42 |
Nfe2l1 |
nuclear factor, erythroid derived 2,-like 1 |
502 |
0.64 |
chr1_24678416_24679325 | 11.40 |
Lmbrd1 |
LMBR1 domain containing 1 |
56 |
0.97 |
chr17_5507754_5507922 | 11.33 |
Zdhhc14 |
zinc finger, DHHC domain containing 14 |
15281 |
0.18 |
chr6_86404113_86404399 | 11.26 |
Tia1 |
cytotoxic granule-associated RNA binding protein 1 |
21 |
0.95 |
chr1_23335409_23335710 | 11.25 |
Gm20954 |
predicted gene, 20954 |
11040 |
0.15 |
chr5_139149689_139150264 | 11.19 |
Prkar1b |
protein kinase, cAMP dependent regulatory, type I beta |
19 |
0.74 |
chr13_99344644_99344831 | 11.19 |
Ptcd2 |
pentatricopeptide repeat domain 2 |
32 |
0.51 |
chr1_119837439_119838190 | 11.15 |
Ptpn4 |
protein tyrosine phosphatase, non-receptor type 4 |
201 |
0.91 |
chr8_94837718_94838480 | 11.11 |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
162 |
0.56 |
chr5_143527920_143528500 | 11.09 |
Rac1 |
Rac family small GTPase 1 |
174 |
0.92 |
chr13_112927323_112927758 | 11.07 |
Dhx29 |
DEAH (Asp-Glu-Ala-His) box polypeptide 29 |
86 |
0.57 |
chr11_120672864_120673079 | 11.04 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
2 |
0.92 |
chr14_41007337_41007980 | 11.01 |
Prxl2a |
peroxiredoxin like 2A |
608 |
0.7 |
chr13_55622910_55623086 | 11.00 |
Caml |
calcium modulating ligand |
7 |
0.96 |
chrX_101273800_101274348 | 10.97 |
Med12 |
mediator complex subunit 12 |
44 |
0.94 |
chr1_156558381_156558873 | 10.89 |
Abl2 |
v-abl Abelson murine leukemia viral oncogene 2 (arg, Abelson-related gene) |
159 |
0.95 |
chr4_129461182_129462057 | 10.82 |
Bsdc1 |
BSD domain containing 1 |
38 |
0.95 |
chr18_36744505_36744698 | 10.81 |
Ndufa2 |
NADH:ubiquinone oxidoreductase subunit A2 |
44 |
0.49 |
chr10_79908828_79909004 | 10.78 |
Med16 |
mediator complex subunit 16 |
5 |
0.76 |
chr16_94569391_94569773 | 10.72 |
Dyrk1a |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1a |
428 |
0.84 |
chrX_73966913_73967094 | 10.70 |
Hcfc1 |
host cell factor C1 |
646 |
0.57 |
chr18_34624504_34624680 | 10.66 |
Brd8 |
bromodomain containing 8 |
9 |
0.49 |
chr8_71950865_71951399 | 10.63 |
Zfp961 |
zinc finger protein 961 |
41 |
0.95 |
chr15_58889255_58889743 | 10.62 |
Gm49356 |
predicted gene, 49356 |
201 |
0.57 |
chr16_91647606_91647943 | 10.60 |
Son |
Son DNA binding protein |
105 |
0.9 |
chr7_16400978_16401382 | 10.59 |
Zc3h4 |
zinc finger CCCH-type containing 4 |
27 |
0.95 |
chr12_13248676_13249586 | 10.57 |
Ddx1 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 1 |
32 |
0.98 |
chr4_127020948_127021345 | 10.54 |
Sfpq |
splicing factor proline/glutamine rich (polypyrimidine tract binding protein associated) |
178 |
0.91 |
chr17_46856748_46856928 | 10.50 |
Bicral |
BRD4 interacting chromatin remodeling complex associated protein like |
1644 |
0.31 |
chrX_50620072_50620237 | 10.46 |
Firre |
functional intergenic repeating RNA element |
14912 |
0.26 |
chr11_116138465_116138898 | 10.45 |
Mrpl38 |
mitochondrial ribosomal protein L38 |
94 |
0.93 |
chr19_4793811_4794180 | 10.44 |
Rbm4 |
RNA binding motif protein 4 |
94 |
0.92 |
chr11_74723503_74724110 | 10.41 |
Pafah1b1 |
platelet-activating factor acetylhydrolase, isoform 1b, subunit 1 |
52 |
0.96 |
chr9_44604815_44605361 | 10.40 |
Ddx6 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 6 |
191 |
0.85 |
chr12_100187417_100188237 | 10.39 |
Gm10433 |
predicted gene 10433 |
141 |
0.89 |
chr7_3644850_3645303 | 10.33 |
Gm15927 |
predicted gene 15927 |
189 |
0.46 |
chr11_50292225_50292589 | 10.29 |
Maml1 |
mastermind like transcriptional coactivator 1 |
96 |
0.95 |
chr5_138619401_138619898 | 10.27 |
Zfp68 |
zinc finger protein 68 |
4 |
0.84 |
chr16_8738602_8739002 | 10.26 |
Usp7 |
ubiquitin specific peptidase 7 |
382 |
0.84 |
chr8_79711585_79712295 | 10.25 |
Anapc10 |
anaphase promoting complex subunit 10 |
89 |
0.65 |
chr1_172126636_172127158 | 10.24 |
Pex19 |
peroxisomal biogenesis factor 19 |
124 |
0.93 |
chr11_74925378_74926625 | 10.22 |
Srr |
serine racemase |
53 |
0.66 |
chr17_35164483_35164674 | 10.22 |
Prrc2a |
proline-rich coiled-coil 2A |
257 |
0.57 |
chr18_35562359_35562576 | 10.21 |
Matr3 |
matrin 3 |
14 |
0.94 |
chr9_31226658_31227012 | 10.12 |
Aplp2 |
amyloid beta (A4) precursor-like protein 2 |
15020 |
0.17 |
chr14_54517330_54517702 | 10.09 |
Prmt5 |
protein arginine N-methyltransferase 5 |
9 |
0.95 |
chr11_115419815_115420841 | 10.08 |
Kctd2 |
potassium channel tetramerisation domain containing 2 |
16 |
0.83 |
chr18_39491521_39492000 | 10.08 |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
459 |
0.88 |
chr9_65196833_65197269 | 10.08 |
Gm25313 |
predicted gene, 25313 |
364 |
0.76 |
chrX_152233152_152233351 | 10.08 |
Kdm5c |
lysine (K)-specific demethylase 5C |
3 |
0.98 |
chr11_4594722_4595031 | 10.04 |
Mtmr3 |
myotubularin related protein 3 |
13 |
0.97 |
chr10_116581436_116581617 | 10.02 |
Cnot2 |
CCR4-NOT transcription complex, subunit 2 |
15 |
0.52 |
chr2_90940139_90940507 | 9.96 |
Celf1 |
CUGBP, Elav-like family member 1 |
59 |
0.95 |
chr17_33915666_33916637 | 9.84 |
Zbtb22 |
zinc finger and BTB domain containing 22 |
20 |
0.48 |
chr5_23418211_23418683 | 9.78 |
5031425E22Rik |
RIKEN cDNA 5031425E22 gene |
14862 |
0.12 |
chr11_83473296_83473679 | 9.73 |
Taf15 |
TATA-box binding protein associated factor 15 |
372 |
0.77 |
chr18_74215663_74216294 | 9.72 |
Cxxc1 |
CXXC finger 1 (PHD domain) |
146 |
0.95 |
chr3_40800170_40800914 | 9.71 |
Plk4 |
polo like kinase 4 |
239 |
0.89 |
chr9_123366732_123367082 | 9.64 |
Lars2 |
leucyl-tRNA synthetase, mitochondrial |
20 |
0.98 |
chr7_111179367_111179913 | 9.61 |
1700012D14Rik |
RIKEN cDNA 1700012D14 gene |
56956 |
0.11 |
chr7_127768560_127769629 | 9.56 |
Orai3 |
ORAI calcium release-activated calcium modulator 3 |
721 |
0.4 |
chr1_179628818_179628987 | 9.54 |
Cnst |
consortin, connexin sorting protein |
35512 |
0.14 |
chr2_105904441_105904760 | 9.51 |
Elp4 |
elongator acetyltransferase complex subunit 4 |
36 |
0.5 |
chr5_100038811_100039161 | 9.50 |
Hnrnpdl |
heterogeneous nuclear ribonucleoprotein D-like |
91 |
0.93 |
chr5_137601005_137601275 | 9.47 |
Mospd3 |
motile sperm domain containing 3 |
82 |
0.81 |
chr14_21052375_21052796 | 9.45 |
Adk |
adenosine kinase |
11 |
0.55 |
chr3_69004761_69005511 | 9.41 |
Smc4 |
structural maintenance of chromosomes 4 |
121 |
0.85 |
chr14_79390171_79390957 | 9.40 |
Naa16 |
N(alpha)-acetyltransferase 16, NatA auxiliary subunit |
126 |
0.95 |
chr2_136891830_136892383 | 9.33 |
Slx4ip |
SLX4 interacting protein |
62 |
0.89 |
chr8_74993554_74993740 | 9.33 |
Hmgxb4 |
HMG box domain containing 4 |
32 |
0.98 |
chr2_162931701_162931928 | 9.32 |
Srsf6 |
serine and arginine-rich splicing factor 6 |
153 |
0.93 |
chr4_132843053_132843349 | 9.31 |
Ppp1r8 |
protein phosphatase 1, regulatory subunit 8 |
32 |
0.96 |
chr9_103223481_103223648 | 9.31 |
Trf |
transferrin |
889 |
0.55 |
chr5_73292944_73293144 | 9.23 |
Ociad1 |
OCIA domain containing 1 |
9 |
0.95 |
chr1_179959300_179959937 | 9.21 |
Cdc42bpa |
CDC42 binding protein kinase alpha |
854 |
0.65 |
chr10_120979315_120979507 | 9.20 |
Lemd3 |
LEM domain containing 3 |
79 |
0.96 |
chr10_111009915_111010090 | 9.18 |
Zdhhc17 |
zinc finger, DHHC domain containing 17 |
1 |
0.98 |
chr8_85025199_85025393 | 9.13 |
Asna1 |
arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) |
15 |
0.91 |
chr18_69344318_69344519 | 9.12 |
Tcf4 |
transcription factor 4 |
71 |
0.98 |
chr11_70525227_70525721 | 9.12 |
Psmb6 |
proteasome (prosome, macropain) subunit, beta type 6 |
88 |
0.91 |
chr12_110737482_110738077 | 9.09 |
Wdr20 |
WD repeat domain 20 |
165 |
0.94 |
chr18_6490312_6490720 | 9.08 |
Mir1893 |
microRNA 1893 |
130 |
0.63 |
chr16_70313843_70314171 | 9.00 |
Gbe1 |
glucan (1,4-alpha-), branching enzyme 1 |
56 |
0.98 |
chr18_7869261_7869796 | 9.00 |
Wac |
WW domain containing adaptor with coiled-coil |
2 |
0.88 |
chrX_50599876_50600033 | 8.94 |
Firre |
functional intergenic repeating RNA element |
7995 |
0.27 |
chr7_90129639_90130990 | 8.93 |
Picalm |
phosphatidylinositol binding clathrin assembly protein |
21 |
0.82 |
chr1_182341562_182341870 | 8.92 |
Fbxo28 |
F-box protein 28 |
87 |
0.97 |
chr9_14380906_14381388 | 8.91 |
Endod1 |
endonuclease domain containing 1 |
95 |
0.95 |
chrX_12297048_12297199 | 8.89 |
Gm14635 |
predicted gene 14635 |
48099 |
0.16 |
chr12_83631993_83632319 | 8.83 |
Rbm25 |
RNA binding motif protein 25 |
96 |
0.94 |
chr4_106315894_106316346 | 8.80 |
Usp24 |
ubiquitin specific peptidase 24 |
93 |
0.96 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.4 | 41.8 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
7.1 | 21.3 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
5.7 | 34.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
5.6 | 22.4 | GO:0006407 | rRNA export from nucleus(GO:0006407) |
5.3 | 15.9 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
5.3 | 21.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
5.0 | 15.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
5.0 | 15.0 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
4.9 | 14.8 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
4.6 | 18.5 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
4.6 | 13.8 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
4.6 | 13.7 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
4.5 | 17.9 | GO:0051660 | establishment of centrosome localization(GO:0051660) |
4.4 | 13.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
4.2 | 12.5 | GO:0031086 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
3.9 | 23.5 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
3.8 | 11.3 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
3.7 | 11.0 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
3.6 | 10.7 | GO:0097167 | circadian regulation of translation(GO:0097167) |
3.5 | 21.3 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
3.5 | 13.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
3.4 | 10.3 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.4 | 13.8 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
3.3 | 10.0 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) |
3.3 | 16.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
3.3 | 22.8 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
3.0 | 8.9 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
3.0 | 11.9 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
3.0 | 11.9 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
3.0 | 23.7 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
2.9 | 8.8 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
2.9 | 8.6 | GO:0019042 | viral latency(GO:0019042) |
2.8 | 8.5 | GO:0019448 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
2.8 | 13.9 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
2.8 | 5.5 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
2.7 | 8.1 | GO:0061535 | glutamate secretion, neurotransmission(GO:0061535) |
2.7 | 8.0 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
2.7 | 61.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
2.6 | 7.9 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
2.5 | 7.5 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
2.5 | 24.9 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
2.4 | 55.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
2.4 | 12.0 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.4 | 4.8 | GO:1905214 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
2.4 | 11.8 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.4 | 11.8 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
2.3 | 4.6 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
2.3 | 13.6 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
2.3 | 9.0 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
2.2 | 8.9 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
2.2 | 13.3 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
2.2 | 6.6 | GO:0021882 | regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment(GO:0021882) commitment of multipotent stem cells to neuronal lineage in forebrain(GO:0021898) |
2.2 | 8.6 | GO:0098535 | de novo centriole assembly(GO:0098535) |
2.1 | 6.4 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
2.1 | 19.2 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
2.1 | 19.2 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
2.1 | 6.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
2.1 | 12.7 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
2.1 | 6.3 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
2.1 | 8.3 | GO:0035627 | ceramide transport(GO:0035627) |
2.1 | 10.4 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
2.1 | 10.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
2.1 | 37.0 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
2.1 | 6.2 | GO:0002071 | glandular epithelial cell maturation(GO:0002071) |
2.0 | 16.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
2.0 | 14.1 | GO:0035459 | cargo loading into vesicle(GO:0035459) |
2.0 | 6.0 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) |
2.0 | 8.0 | GO:1905206 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.9 | 7.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.9 | 3.8 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
1.9 | 7.7 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
1.9 | 7.7 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
1.9 | 11.5 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
1.9 | 5.7 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
1.9 | 5.7 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
1.9 | 7.5 | GO:0018343 | protein farnesylation(GO:0018343) |
1.8 | 16.6 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
1.8 | 5.5 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
1.8 | 5.4 | GO:0042117 | monocyte activation(GO:0042117) |
1.8 | 21.4 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
1.7 | 7.0 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
1.7 | 7.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
1.7 | 7.0 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
1.7 | 10.4 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
1.7 | 10.4 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
1.7 | 10.3 | GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb(GO:0022028) |
1.7 | 5.1 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
1.7 | 10.2 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
1.6 | 4.9 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
1.6 | 8.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
1.6 | 13.0 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
1.6 | 8.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.6 | 6.4 | GO:0009838 | abscission(GO:0009838) |
1.6 | 11.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
1.6 | 7.8 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
1.6 | 43.8 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
1.6 | 4.7 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
1.5 | 10.7 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
1.5 | 18.4 | GO:0043248 | proteasome assembly(GO:0043248) |
1.5 | 4.6 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
1.5 | 9.1 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
1.5 | 4.6 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
1.5 | 6.1 | GO:0000414 | regulation of histone H3-K36 methylation(GO:0000414) |
1.5 | 3.0 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
1.5 | 4.5 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
1.5 | 4.4 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
1.5 | 10.3 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
1.5 | 4.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
1.4 | 4.3 | GO:2001274 | negative regulation of glucose import in response to insulin stimulus(GO:2001274) |
1.4 | 12.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
1.4 | 19.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
1.4 | 5.5 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
1.4 | 6.8 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
1.4 | 10.9 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
1.4 | 14.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
1.4 | 9.5 | GO:0070070 | proton-transporting V-type ATPase complex assembly(GO:0070070) |
1.3 | 18.9 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
1.3 | 12.0 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
1.3 | 7.7 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
1.3 | 12.7 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
1.3 | 5.1 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
1.3 | 8.8 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
1.3 | 5.0 | GO:0034454 | microtubule anchoring at centrosome(GO:0034454) |
1.3 | 10.1 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
1.3 | 3.8 | GO:0033092 | positive regulation of immature T cell proliferation in thymus(GO:0033092) |
1.2 | 22.4 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
1.2 | 7.4 | GO:0042118 | endothelial cell activation(GO:0042118) |
1.2 | 3.7 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.2 | 2.5 | GO:1900222 | negative regulation of beta-amyloid clearance(GO:1900222) |
1.2 | 3.7 | GO:0060336 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
1.2 | 8.5 | GO:0007021 | tubulin complex assembly(GO:0007021) |
1.2 | 3.6 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
1.2 | 6.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
1.2 | 3.6 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
1.2 | 3.6 | GO:0070375 | ERK5 cascade(GO:0070375) |
1.2 | 3.6 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
1.2 | 4.7 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
1.2 | 11.7 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
1.2 | 15.0 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
1.2 | 11.5 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
1.2 | 17.3 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
1.1 | 6.8 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
1.1 | 4.5 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
1.1 | 2.2 | GO:1903626 | positive regulation of apoptotic DNA fragmentation(GO:1902512) positive regulation of DNA catabolic process(GO:1903626) |
1.1 | 3.2 | GO:0044838 | cell quiescence(GO:0044838) |
1.1 | 4.3 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
1.1 | 2.1 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
1.0 | 6.2 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
1.0 | 2.0 | GO:0061502 | early endosome to recycling endosome transport(GO:0061502) |
1.0 | 4.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
1.0 | 2.0 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
1.0 | 13.0 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
1.0 | 14.9 | GO:0060009 | Sertoli cell development(GO:0060009) |
1.0 | 8.9 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
1.0 | 4.9 | GO:0043486 | histone exchange(GO:0043486) |
1.0 | 20.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
1.0 | 60.9 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
1.0 | 3.8 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.9 | 4.7 | GO:0015074 | DNA integration(GO:0015074) |
0.9 | 1.9 | GO:0036480 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.9 | 2.8 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.9 | 43.4 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.9 | 4.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.9 | 2.8 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.9 | 14.0 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.9 | 20.5 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.9 | 2.8 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.9 | 39.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.9 | 13.7 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.9 | 10.9 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.9 | 9.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.9 | 3.6 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
0.9 | 2.7 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.9 | 3.4 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.9 | 2.6 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.8 | 1.7 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.8 | 1.7 | GO:2000313 | fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
0.8 | 1.7 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.8 | 2.5 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 5.0 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
0.8 | 24.2 | GO:0007062 | sister chromatid cohesion(GO:0007062) |
0.8 | 0.8 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.8 | 4.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.8 | 4.9 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.8 | 2.4 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.8 | 1.6 | GO:0060060 | post-embryonic retina morphogenesis in camera-type eye(GO:0060060) |
0.8 | 16.1 | GO:0007099 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
0.8 | 10.6 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.7 | 1.5 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.7 | 6.7 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.7 | 3.7 | GO:0060177 | regulation of angiotensin metabolic process(GO:0060177) |
0.7 | 8.2 | GO:0009263 | deoxyribonucleotide biosynthetic process(GO:0009263) |
0.7 | 2.2 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
0.7 | 1.5 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
0.7 | 5.9 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.7 | 2.2 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.7 | 1.5 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.7 | 2.9 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
0.7 | 3.6 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.7 | 3.6 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.7 | 4.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.7 | 4.2 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.7 | 2.1 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.7 | 9.9 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.7 | 4.9 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.7 | 7.0 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.7 | 3.5 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.7 | 2.8 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.7 | 1.4 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) |
0.7 | 3.4 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.7 | 9.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.7 | 2.0 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.7 | 3.4 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.7 | 0.7 | GO:0007228 | positive regulation of hh target transcription factor activity(GO:0007228) |
0.7 | 6.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.7 | 2.0 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 4.6 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.7 | 3.3 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.7 | 5.3 | GO:0021684 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.7 | 4.6 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.7 | 2.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.7 | 0.7 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.7 | 7.2 | GO:0010225 | response to UV-C(GO:0010225) |
0.6 | 5.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.6 | 1.3 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.6 | 0.6 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.6 | 1.9 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.6 | 5.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.6 | 1.9 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.6 | 3.2 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.6 | 14.6 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.6 | 0.6 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.6 | 7.5 | GO:0010960 | magnesium ion homeostasis(GO:0010960) |
0.6 | 1.3 | GO:0030242 | pexophagy(GO:0030242) |
0.6 | 11.3 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.6 | 3.1 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.6 | 4.9 | GO:0097033 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.6 | 8.6 | GO:0030488 | tRNA methylation(GO:0030488) |
0.6 | 1.8 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.6 | 2.4 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.6 | 3.0 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.6 | 1.2 | GO:0090399 | replicative senescence(GO:0090399) |
0.6 | 6.6 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.6 | 1.8 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.6 | 3.5 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) |
0.6 | 1.7 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.6 | 4.6 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.6 | 2.9 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.6 | 4.5 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
0.6 | 1.7 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.6 | 1.7 | GO:0018027 | peptidyl-lysine dimethylation(GO:0018027) |
0.6 | 12.7 | GO:0003170 | heart valve development(GO:0003170) |
0.5 | 8.8 | GO:0006221 | pyrimidine nucleotide biosynthetic process(GO:0006221) |
0.5 | 2.7 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.5 | 6.0 | GO:2000785 | regulation of autophagosome assembly(GO:2000785) |
0.5 | 3.8 | GO:0006415 | translational termination(GO:0006415) |
0.5 | 3.7 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.5 | 2.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.5 | 1.6 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.5 | 2.1 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.5 | 1.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.5 | 3.1 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.5 | 2.1 | GO:0061687 | detoxification of inorganic compound(GO:0061687) |
0.5 | 3.7 | GO:0033572 | transferrin transport(GO:0033572) |
0.5 | 1.0 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.5 | 2.1 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043328) |
0.5 | 15.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.5 | 1.0 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 15.5 | GO:0016239 | positive regulation of macroautophagy(GO:0016239) |
0.5 | 10.8 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.5 | 3.1 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.5 | 8.2 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.5 | 13.7 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.5 | 1.0 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.5 | 1.5 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.5 | 3.5 | GO:0080182 | histone H3-K4 trimethylation(GO:0080182) |
0.5 | 5.0 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.5 | 2.5 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.5 | 4.0 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.5 | 2.0 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.5 | 2.0 | GO:0032785 | negative regulation of DNA-templated transcription, elongation(GO:0032785) |
0.5 | 1.5 | GO:1902218 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.5 | 0.5 | GO:0007296 | vitellogenesis(GO:0007296) |
0.5 | 1.4 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.5 | 1.9 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.5 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 4.2 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.5 | 5.2 | GO:0031571 | mitotic G1 DNA damage checkpoint(GO:0031571) G1 DNA damage checkpoint(GO:0044783) |
0.5 | 4.2 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
0.5 | 2.8 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.5 | 1.4 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.5 | 1.4 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 1.4 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.4 | 1.3 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.4 | 4.0 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.4 | 2.2 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.4 | 4.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.4 | 0.9 | GO:0072366 | regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter(GO:0072366) |
0.4 | 4.8 | GO:0035066 | positive regulation of histone acetylation(GO:0035066) |
0.4 | 6.5 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 2.2 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.4 | 6.5 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.4 | 5.6 | GO:0001881 | receptor recycling(GO:0001881) |
0.4 | 8.6 | GO:0006400 | tRNA modification(GO:0006400) |
0.4 | 3.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.4 | 1.3 | GO:0038180 | nerve growth factor signaling pathway(GO:0038180) |
0.4 | 0.4 | GO:0021590 | cerebellum maturation(GO:0021590) |
0.4 | 6.8 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.4 | 2.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.4 | 7.7 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.4 | 3.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.4 | 3.8 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.4 | 2.5 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.4 | 2.5 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.3 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 1.3 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.4 | 4.6 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.4 | 5.0 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.4 | 2.5 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.4 | 10.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 2.1 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 3.3 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.4 | 2.5 | GO:2000058 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000058) |
0.4 | 3.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.4 | 1.2 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.4 | 4.5 | GO:0030220 | platelet formation(GO:0030220) |
0.4 | 13.1 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.4 | 1.2 | GO:0070475 | rRNA base methylation(GO:0070475) |
0.4 | 0.8 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
0.4 | 2.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.4 | 11.2 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.4 | 10.0 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.4 | 1.6 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.4 | 0.8 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.4 | 0.8 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 0.4 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.4 | 2.7 | GO:0046628 | positive regulation of insulin receptor signaling pathway(GO:0046628) |
0.4 | 2.7 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.4 | 0.8 | GO:0051295 | polar body extrusion after meiotic divisions(GO:0040038) establishment of meiotic spindle localization(GO:0051295) formin-nucleated actin cable assembly(GO:0070649) |
0.4 | 1.2 | GO:0098787 | mRNA cleavage involved in mRNA processing(GO:0098787) |
0.4 | 10.7 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.4 | 1.5 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.4 | 1.5 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.4 | 2.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.4 | 9.3 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.4 | 1.9 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.4 | 0.7 | GO:0001844 | protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:0001844) |
0.4 | 0.4 | GO:0070384 | Harderian gland development(GO:0070384) |
0.4 | 1.5 | GO:0070572 | positive regulation of neuron projection regeneration(GO:0070572) |
0.4 | 0.7 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.4 | 7.0 | GO:0033598 | mammary gland epithelial cell proliferation(GO:0033598) |
0.4 | 2.2 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.4 | 2.2 | GO:0034728 | nucleosome organization(GO:0034728) |
0.4 | 1.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.4 | 1.8 | GO:0009048 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.4 | 2.1 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.4 | 0.4 | GO:1901985 | positive regulation of protein acetylation(GO:1901985) |
0.3 | 1.0 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 0.7 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.3 | 1.4 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.3 | 8.2 | GO:0006352 | DNA-templated transcription, initiation(GO:0006352) |
0.3 | 0.3 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.3 | 1.0 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.3 | 3.1 | GO:0016926 | protein desumoylation(GO:0016926) |
0.3 | 2.0 | GO:0043247 | telomere maintenance in response to DNA damage(GO:0043247) |
0.3 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 0.7 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.3 | 2.0 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.3 | 0.3 | GO:0061050 | regulation of cell growth involved in cardiac muscle cell development(GO:0061050) |
0.3 | 3.3 | GO:0046040 | IMP metabolic process(GO:0046040) |
0.3 | 1.0 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.3 | 3.6 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.3 | 3.5 | GO:0030330 | DNA damage response, signal transduction by p53 class mediator(GO:0030330) |
0.3 | 0.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.3 | 0.6 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.3 | 3.5 | GO:0071548 | response to dexamethasone(GO:0071548) |
0.3 | 1.0 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.3 | 6.0 | GO:0001958 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.3 | 0.3 | GO:0070828 | heterochromatin organization(GO:0070828) |
0.3 | 5.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.3 | 7.8 | GO:2001239 | regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001239) |
0.3 | 3.1 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.3 | 0.3 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
0.3 | 0.3 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.3 | 7.1 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 4.3 | GO:0001539 | cilium or flagellum-dependent cell motility(GO:0001539) cilium-dependent cell motility(GO:0060285) |
0.3 | 13.0 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.3 | 1.5 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.3 | 1.9 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.3 | 0.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.3 | 3.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.3 | 3.0 | GO:0035994 | response to muscle stretch(GO:0035994) |
0.3 | 5.7 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 4.7 | GO:0000469 | cleavage involved in rRNA processing(GO:0000469) |
0.3 | 2.4 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
0.3 | 4.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.3 | 12.1 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.3 | 2.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.3 | 0.3 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.3 | 2.0 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 0.3 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
0.3 | 3.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.3 | 0.9 | GO:1902993 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.3 | 5.2 | GO:0007520 | myoblast fusion(GO:0007520) |
0.3 | 1.7 | GO:0002349 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
0.3 | 4.5 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.3 | 2.8 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 2.8 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.3 | 7.5 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.3 | 0.6 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.3 | 0.3 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.3 | 7.2 | GO:1901998 | toxin transport(GO:1901998) |
0.3 | 1.1 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.3 | 10.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.3 | 2.2 | GO:2000009 | negative regulation of protein localization to cell surface(GO:2000009) |
0.3 | 3.5 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 3.2 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.3 | 3.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 1.9 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.3 | 2.9 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 0.5 | GO:0050904 | diapedesis(GO:0050904) |
0.3 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.3 | 2.3 | GO:0051481 | negative regulation of cytosolic calcium ion concentration(GO:0051481) |
0.3 | 0.5 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.3 | 0.8 | GO:0060068 | vagina development(GO:0060068) |
0.3 | 1.8 | GO:0051642 | centrosome localization(GO:0051642) |
0.3 | 0.3 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.3 | 0.8 | GO:0030920 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.2 | 2.0 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.2 | 0.2 | GO:0032430 | positive regulation of phospholipase A2 activity(GO:0032430) |
0.2 | 4.3 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.2 | 0.2 | GO:0048143 | astrocyte activation(GO:0048143) |
0.2 | 0.7 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.2 | 7.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.2 | 5.6 | GO:0043297 | apical junction assembly(GO:0043297) |
0.2 | 6.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.2 | 1.4 | GO:0051382 | kinetochore assembly(GO:0051382) |
0.2 | 0.2 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.2 | 1.6 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.2 | 0.7 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 3.9 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.2 | 5.5 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.2 | 0.7 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) |
0.2 | 8.7 | GO:0032272 | negative regulation of protein polymerization(GO:0032272) |
0.2 | 4.1 | GO:0000266 | mitochondrial fission(GO:0000266) |
0.2 | 0.7 | GO:0048254 | snoRNA localization(GO:0048254) |
0.2 | 3.9 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.2 | 2.0 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.2 | 2.9 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.2 | 4.3 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.2 | 0.7 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
0.2 | 0.7 | GO:0046836 | glycolipid transport(GO:0046836) |
0.2 | 0.9 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.2 | 2.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.2 | 0.9 | GO:0032211 | negative regulation of telomere maintenance via telomerase(GO:0032211) |
0.2 | 0.4 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.2 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 1.7 | GO:0009062 | fatty acid catabolic process(GO:0009062) |
0.2 | 0.2 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.2 | 0.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
0.2 | 2.1 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.2 | 2.6 | GO:0043304 | regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
0.2 | 0.6 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.2 | 0.9 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.2 | 18.2 | GO:0042787 | protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0042787) |
0.2 | 13.6 | GO:0098792 | xenophagy(GO:0098792) |
0.2 | 0.2 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.2 | 1.5 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.2 | 2.1 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
0.2 | 7.4 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.2 | 1.2 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.0 | GO:0034312 | diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) |
0.2 | 1.2 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.2 | 9.3 | GO:1903955 | positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.2 | 0.4 | GO:0031635 | adenylate cyclase-inhibiting opioid receptor signaling pathway(GO:0031635) |
0.2 | 0.6 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.2 | 0.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 1.4 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.2 | 0.6 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.8 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.2 | 0.2 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.2 | 2.2 | GO:0071427 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.2 | 1.2 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.2 | 1.0 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.2 | 0.4 | GO:0046543 | development of secondary female sexual characteristics(GO:0046543) |
0.2 | 1.4 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.2 | 5.6 | GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043154) |
0.2 | 0.2 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.6 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.2 | 0.2 | GO:0016441 | posttranscriptional gene silencing(GO:0016441) |
0.2 | 0.8 | GO:0033004 | negative regulation of mast cell activation(GO:0033004) |
0.2 | 0.6 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.2 | 1.0 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 4.2 | GO:0030901 | midbrain development(GO:0030901) |
0.2 | 0.4 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 0.6 | GO:0060023 | soft palate development(GO:0060023) |
0.2 | 0.4 | GO:0035928 | rRNA import into mitochondrion(GO:0035928) |
0.2 | 0.8 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.2 | 7.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.2 | 7.6 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.2 | 0.5 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 0.5 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.2 | 0.4 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 0.4 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 0.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.2 | 0.5 | GO:0023035 | CD40 signaling pathway(GO:0023035) regulation of CD40 signaling pathway(GO:2000348) |
0.2 | 0.5 | GO:1900378 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
0.2 | 0.5 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.2 | 5.2 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 0.3 | GO:0043302 | positive regulation of leukocyte degranulation(GO:0043302) |
0.2 | 1.2 | GO:0010165 | response to X-ray(GO:0010165) |
0.2 | 0.2 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
0.2 | 0.2 | GO:0042701 | progesterone secretion(GO:0042701) |
0.2 | 4.3 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.2 | 0.5 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.2 | 1.0 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.2 | 1.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 6.5 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
0.2 | 2.3 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.2 | 0.8 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 0.5 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.2 | 1.6 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
0.2 | 0.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.2 | 0.6 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.5 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
0.2 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.9 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 0.8 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.2 | 0.3 | GO:2000973 | regulation of pro-B cell differentiation(GO:2000973) |
0.2 | 1.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.2 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.2 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.2 | 0.5 | GO:0060267 | positive regulation of respiratory burst(GO:0060267) |
0.2 | 0.5 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.2 | 0.9 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.2 | 6.5 | GO:0008584 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.2 | 0.2 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.5 | GO:0007619 | courtship behavior(GO:0007619) |
0.1 | 0.4 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.6 | GO:0044557 | relaxation of smooth muscle(GO:0044557) relaxation of vascular smooth muscle(GO:0060087) |
0.1 | 0.1 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.3 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.1 | 2.1 | GO:2000398 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 1.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.1 | 0.9 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 0.1 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.1 | 0.3 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.1 | 0.1 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.1 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.1 | 0.4 | GO:0061589 | calcium activated phosphatidylserine scrambling(GO:0061589) |
0.1 | 0.6 | GO:0019695 | choline metabolic process(GO:0019695) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 3.3 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.1 | 0.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.1 | 1.5 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 0.3 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.4 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.1 | 0.4 | GO:0030575 | nuclear body organization(GO:0030575) |
0.1 | 0.7 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.1 | 0.9 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.1 | 0.1 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 0.5 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.1 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
0.1 | 0.2 | GO:0002159 | desmosome assembly(GO:0002159) |
0.1 | 1.1 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.6 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0030033 | microvillus assembly(GO:0030033) |
0.1 | 2.0 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.1 | 1.7 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.1 | 0.2 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 1.1 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.1 | 0.6 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.1 | 0.1 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.1 | 0.2 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.1 | 1.7 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.4 | GO:0030835 | negative regulation of actin filament depolymerization(GO:0030835) |
0.1 | 1.1 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.4 | GO:0017145 | stem cell division(GO:0017145) |
0.1 | 0.1 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) |
0.1 | 1.0 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 3.6 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.2 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 0.3 | GO:0006896 | Golgi to vacuole transport(GO:0006896) |
0.1 | 0.1 | GO:0010870 | positive regulation of receptor biosynthetic process(GO:0010870) |
0.1 | 0.2 | GO:1903679 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 3.3 | GO:0031398 | positive regulation of protein ubiquitination(GO:0031398) |
0.1 | 11.4 | GO:0007059 | chromosome segregation(GO:0007059) |
0.1 | 0.6 | GO:0010224 | response to UV-B(GO:0010224) |
0.1 | 0.2 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.1 | 2.2 | GO:0043966 | histone H3 acetylation(GO:0043966) |
0.1 | 0.1 | GO:0034969 | histone arginine methylation(GO:0034969) |
0.1 | 1.3 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.1 | 0.4 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 7.6 | GO:0006457 | protein folding(GO:0006457) |
0.1 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.1 | 1.0 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.3 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.1 | 1.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.2 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 1.1 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 2.2 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.1 | 0.7 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 2.5 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
0.1 | 1.1 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.1 | 0.3 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.1 | 0.3 | GO:0001692 | histamine metabolic process(GO:0001692) |
0.1 | 1.0 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.1 | 1.0 | GO:0050435 | beta-amyloid metabolic process(GO:0050435) |
0.1 | 0.1 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.1 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.1 | 0.8 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.1 | 0.6 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.2 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) |
0.1 | 0.2 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.1 | 2.9 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 0.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.1 | 0.2 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
0.1 | 0.3 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
0.1 | 0.2 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.3 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.1 | 1.3 | GO:0034219 | carbohydrate transmembrane transport(GO:0034219) |
0.1 | 0.8 | GO:0043488 | regulation of mRNA stability(GO:0043488) |
0.1 | 0.3 | GO:1901185 | negative regulation of ERBB signaling pathway(GO:1901185) |
0.1 | 0.6 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.2 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) |
0.1 | 0.4 | GO:0030049 | muscle filament sliding(GO:0030049) |
0.1 | 0.1 | GO:0001698 | gastrin-induced gastric acid secretion(GO:0001698) |
0.1 | 0.3 | GO:0080111 | DNA demethylation(GO:0080111) |
0.1 | 0.3 | GO:0045542 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.1 | 0.2 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.2 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.1 | 0.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.2 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.2 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 1.4 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 1.9 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.1 | 0.6 | GO:0042255 | ribosome assembly(GO:0042255) |
0.1 | 2.9 | GO:0071897 | DNA biosynthetic process(GO:0071897) |
0.1 | 0.3 | GO:0006513 | protein monoubiquitination(GO:0006513) |
0.1 | 0.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.2 | GO:0002586 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 0.2 | GO:0030421 | defecation(GO:0030421) |
0.1 | 23.4 | GO:0006412 | translation(GO:0006412) |
0.1 | 0.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.1 | GO:0008228 | opsonization(GO:0008228) |
0.1 | 0.1 | GO:1902992 | negative regulation of amyloid precursor protein catabolic process(GO:1902992) |
0.1 | 0.1 | GO:0048069 | eye pigmentation(GO:0048069) |
0.1 | 0.3 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.1 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.4 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.5 | GO:0007093 | mitotic cell cycle checkpoint(GO:0007093) |
0.1 | 0.1 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.1 | 0.4 | GO:0090109 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.1 | 0.1 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 1.3 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.1 | 0.3 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.5 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.1 | 0.5 | GO:0060337 | type I interferon signaling pathway(GO:0060337) |
0.1 | 2.0 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 0.1 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
0.1 | 4.1 | GO:0033673 | negative regulation of kinase activity(GO:0033673) |
0.1 | 0.2 | GO:0002689 | negative regulation of leukocyte chemotaxis(GO:0002689) |
0.1 | 0.4 | GO:0002313 | mature B cell differentiation involved in immune response(GO:0002313) |
0.1 | 3.0 | GO:0008033 | tRNA processing(GO:0008033) |
0.1 | 0.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.1 | 2.3 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.1 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.1 | 0.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.5 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
0.1 | 0.3 | GO:0050482 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.1 | 0.4 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.1 | 0.8 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.3 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.1 | 0.1 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.1 | 0.1 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.2 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.1 | 0.3 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 0.1 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.1 | 0.1 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.1 | 0.2 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.1 | 0.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.1 | GO:0071467 | cellular response to pH(GO:0071467) |
0.1 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
0.1 | 0.5 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.1 | 0.1 | GO:0070391 | response to lipoteichoic acid(GO:0070391) cellular response to lipoteichoic acid(GO:0071223) |
0.1 | 0.7 | GO:0006536 | glutamate metabolic process(GO:0006536) |
0.1 | 0.3 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 7.3 | GO:0032259 | methylation(GO:0032259) |
0.1 | 0.1 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.2 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.1 | 0.1 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.1 | 0.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.2 | GO:0001945 | lymph vessel development(GO:0001945) |
0.1 | 0.4 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.1 | 0.5 | GO:0006622 | protein targeting to lysosome(GO:0006622) |
0.1 | 0.2 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
0.1 | 0.1 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 0.3 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.1 | 0.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.1 | 0.4 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 4.0 | GO:0043547 | positive regulation of GTPase activity(GO:0043547) |
0.1 | 0.1 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 4.0 | GO:0006913 | nucleocytoplasmic transport(GO:0006913) |
0.1 | 4.0 | GO:0008360 | regulation of cell shape(GO:0008360) |
0.1 | 0.1 | GO:2000010 | positive regulation of protein localization to cell surface(GO:2000010) |
0.1 | 0.1 | GO:0021800 | cerebral cortex tangential migration(GO:0021800) |
0.1 | 0.6 | GO:0072678 | T cell migration(GO:0072678) |
0.1 | 0.1 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 0.4 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.1 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.1 | 0.1 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.1 | 0.1 | GO:0052173 | response to defenses of other organism involved in symbiotic interaction(GO:0052173) response to host defenses(GO:0052200) response to host(GO:0075136) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.1 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.1 | 0.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.1 | 0.1 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.1 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.2 | GO:0060039 | pericardium development(GO:0060039) |
0.1 | 3.9 | GO:0006821 | chloride transport(GO:0006821) |
0.1 | 0.1 | GO:0032460 | negative regulation of protein oligomerization(GO:0032460) |
0.1 | 0.4 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
0.1 | 0.1 | GO:0010677 | negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
0.0 | 0.1 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 0.8 | GO:0001885 | endothelial cell development(GO:0001885) |
0.0 | 0.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.0 | 0.6 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.0 | 0.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.0 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.0 | 0.1 | GO:0001553 | luteinization(GO:0001553) |
0.0 | 0.0 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.0 | 0.3 | GO:0031333 | negative regulation of protein complex assembly(GO:0031333) |
0.0 | 4.7 | GO:0030335 | positive regulation of cell migration(GO:0030335) |
0.0 | 0.1 | GO:0048102 | autophagic cell death(GO:0048102) |
0.0 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.0 | 0.4 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.0 | 0.0 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.4 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.0 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.0 | 0.3 | GO:0090077 | foam cell differentiation(GO:0090077) |
0.0 | 0.4 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.0 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.0 | 0.1 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 0.1 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
0.0 | 0.1 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
0.0 | 0.1 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 1.6 | GO:0048675 | axon extension(GO:0048675) |
0.0 | 0.0 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
0.0 | 0.0 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.0 | 1.0 | GO:0051453 | regulation of intracellular pH(GO:0051453) |
0.0 | 0.3 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.0 | 0.0 | GO:1901201 | regulation of extracellular matrix assembly(GO:1901201) |
0.0 | 0.1 | GO:0010800 | positive regulation of peptidyl-threonine phosphorylation(GO:0010800) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.2 | GO:0036035 | osteoclast development(GO:0036035) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
0.0 | 0.1 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.3 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.0 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0061622 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process through glucose-1-phosphate(GO:0061622) glycolytic process from galactose(GO:0061623) |
0.0 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.0 | 0.2 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.1 | GO:1901163 | regulation of trophoblast cell migration(GO:1901163) |
0.0 | 0.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.0 | 0.3 | GO:0060612 | adipose tissue development(GO:0060612) |
0.0 | 0.1 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.0 | 0.3 | GO:0098927 | vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 0.1 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
0.0 | 0.0 | GO:0003207 | cardiac chamber formation(GO:0003207) |
0.0 | 0.1 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.0 | 0.0 | GO:1903579 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.6 | GO:0072350 | tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.0 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.0 | 0.4 | GO:0014850 | response to muscle activity(GO:0014850) |
0.0 | 1.6 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.0 | 0.0 | GO:2001187 | positive regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000566) positive regulation of CD8-positive, alpha-beta T cell activation(GO:2001187) |
0.0 | 0.1 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 0.1 | GO:0072718 | response to cisplatin(GO:0072718) |
0.0 | 0.1 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.0 | GO:0002086 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.0 | 0.2 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.0 | 0.7 | GO:0071774 | response to fibroblast growth factor(GO:0071774) |
0.0 | 0.1 | GO:0043388 | positive regulation of DNA binding(GO:0043388) |
0.0 | 0.3 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 0.0 | GO:0015684 | ferrous iron transport(GO:0015684) |
0.0 | 0.2 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.1 | GO:0071870 | cellular response to catecholamine stimulus(GO:0071870) |
0.0 | 0.2 | GO:0097352 | autophagosome maturation(GO:0097352) |
0.0 | 0.0 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.0 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.0 | 0.1 | GO:1901991 | negative regulation of mitotic cell cycle phase transition(GO:1901991) |
0.0 | 0.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.0 | 0.0 | GO:0097501 | stress response to metal ion(GO:0097501) |
0.0 | 0.0 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.0 | 0.9 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.0 | 0.0 | GO:0030730 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
0.0 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0046337 | phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
0.0 | 0.1 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.0 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.0 | 0.1 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.0 | 0.4 | GO:1901216 | positive regulation of neuron death(GO:1901216) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.0 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.0 | 0.0 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.0 | 0.1 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
0.0 | 0.0 | GO:0043300 | regulation of leukocyte degranulation(GO:0043300) |
0.0 | 0.1 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
0.0 | 0.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.0 | 2.1 | GO:0009615 | response to virus(GO:0009615) |
0.0 | 0.0 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
0.0 | 0.0 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.0 | 0.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.0 | 0.1 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.0 | 0.1 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
0.0 | 0.0 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.0 | 0.0 | GO:0060157 | urinary bladder development(GO:0060157) |
0.0 | 0.0 | GO:0051385 | response to mineralocorticoid(GO:0051385) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 1.0 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
0.0 | 0.1 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.0 | 0.1 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.0 | 0.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.1 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 1.2 | GO:0007224 | smoothened signaling pathway(GO:0007224) |
0.0 | 0.0 | GO:0090069 | regulation of ribosome biogenesis(GO:0090069) |
0.0 | 0.4 | GO:0050852 | T cell receptor signaling pathway(GO:0050852) |
0.0 | 2.1 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.0 | 0.5 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.0 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.0 | 0.7 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.2 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) negative thymic T cell selection(GO:0045060) |
0.0 | 0.1 | GO:0030826 | regulation of cGMP biosynthetic process(GO:0030826) |
0.0 | 0.1 | GO:0015888 | thiamine transport(GO:0015888) |
0.0 | 0.1 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.0 | 0.4 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0002485 | antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway(GO:0002484) antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent(GO:0002485) |
0.0 | 0.8 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.1 | GO:0040018 | positive regulation of multicellular organism growth(GO:0040018) |
0.0 | 0.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.0 | 0.0 | GO:0070417 | cellular response to cold(GO:0070417) |
0.0 | 0.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.0 | 1.4 | GO:0050796 | regulation of insulin secretion(GO:0050796) |
0.0 | 0.1 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.0 | 0.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.0 | 0.1 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.1 | GO:1902116 | negative regulation of organelle assembly(GO:1902116) |
0.0 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.0 | 0.2 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.0 | 0.1 | GO:0070266 | necroptotic process(GO:0070266) |
0.0 | 0.1 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) |
0.0 | 0.1 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.0 | 0.0 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.0 | 0.0 | GO:0021586 | pons maturation(GO:0021586) |
0.0 | 0.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.0 | 0.0 | GO:0010882 | regulation of cardiac muscle contraction by calcium ion signaling(GO:0010882) |
0.0 | 0.4 | GO:0009225 | nucleotide-sugar metabolic process(GO:0009225) |
0.0 | 0.1 | GO:0010664 | negative regulation of striated muscle cell apoptotic process(GO:0010664) |
0.0 | 0.0 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.0 | 0.1 | GO:0061640 | cytoskeleton-dependent cytokinesis(GO:0061640) |
0.0 | 0.0 | GO:0006356 | regulation of transcription from RNA polymerase I promoter(GO:0006356) |
0.0 | 0.0 | GO:0000279 | M phase(GO:0000279) |
0.0 | 0.0 | GO:0060022 | hard palate development(GO:0060022) |
0.0 | 0.1 | GO:0044146 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.0 | GO:1902474 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.1 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.0 | 0.1 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.0 | 0.0 | GO:1900038 | negative regulation of cellular response to hypoxia(GO:1900038) |
0.0 | 0.0 | GO:0009946 | proximal/distal axis specification(GO:0009946) |
0.0 | 0.0 | GO:0048485 | sympathetic nervous system development(GO:0048485) |
0.0 | 0.1 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.0 | GO:0002091 | negative regulation of receptor internalization(GO:0002091) |
0.0 | 0.0 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.0 | 0.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
0.0 | 0.2 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.1 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
0.0 | 0.0 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.0 | 0.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.0 | 0.0 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.0 | 0.0 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.0 | 0.0 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.0 | GO:0021819 | layer formation in cerebral cortex(GO:0021819) |
0.0 | 0.5 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.0 | 0.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.1 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
0.0 | 0.1 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.0 | 0.0 | GO:0007000 | nucleolus organization(GO:0007000) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.0 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.0 | 0.1 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.0 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
0.0 | 0.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 0.1 | GO:0052805 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.0 | 0.0 | GO:0070344 | fat cell proliferation(GO:0070341) regulation of fat cell proliferation(GO:0070344) |
0.0 | 0.8 | GO:0046777 | protein autophosphorylation(GO:0046777) |
0.0 | 0.0 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
0.0 | 0.2 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.0 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
0.0 | 0.0 | GO:0050755 | chemokine metabolic process(GO:0050755) |
0.0 | 0.0 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.0 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.0 | GO:0045918 | regulation of cytolysis(GO:0042268) negative regulation of cytolysis(GO:0045918) |
0.0 | 0.1 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.0 | 0.1 | GO:0007031 | peroxisome organization(GO:0007031) |
0.0 | 0.1 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.1 | GO:0097150 | neuronal stem cell population maintenance(GO:0097150) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.0 | GO:0033058 | directional locomotion(GO:0033058) |
0.0 | 0.3 | GO:0021954 | central nervous system neuron development(GO:0021954) |
0.0 | 0.0 | GO:0060572 | morphogenesis of an epithelial bud(GO:0060572) |
0.0 | 0.1 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) negative regulation of actin nucleation(GO:0051126) |
0.0 | 0.0 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.0 | 0.1 | GO:0048535 | lymph node development(GO:0048535) |
0.0 | 0.0 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.0 | 2.0 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.0 | GO:0060789 | hair follicle placode formation(GO:0060789) |
0.0 | 0.1 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.0 | 0.0 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.0 | GO:0042987 | amyloid precursor protein catabolic process(GO:0042987) |
0.0 | 0.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.0 | 0.0 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.0 | 0.0 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
0.0 | 0.0 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.0 | 0.0 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.0 | 0.1 | GO:0034113 | heterotypic cell-cell adhesion(GO:0034113) |
0.0 | 0.0 | GO:0031000 | response to caffeine(GO:0031000) |
0.0 | 0.0 | GO:0043382 | regulation of memory T cell differentiation(GO:0043380) positive regulation of memory T cell differentiation(GO:0043382) |
0.0 | 0.0 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.0 | 0.1 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.0 | 0.0 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.0 | 0.0 | GO:0042074 | cell migration involved in gastrulation(GO:0042074) |
0.0 | 0.2 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.0 | 0.0 | GO:1902743 | regulation of lamellipodium organization(GO:1902743) |
0.0 | 0.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.0 | 0.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.0 | GO:0009950 | dorsal/ventral axis specification(GO:0009950) |
0.0 | 0.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.0 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0060480 | lung goblet cell differentiation(GO:0060480) |
0.0 | 0.0 | GO:0070255 | regulation of mucus secretion(GO:0070255) |
0.0 | 0.0 | GO:0006561 | proline biosynthetic process(GO:0006561) |
0.0 | 0.0 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.0 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0002029 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 0.0 | GO:0045631 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.0 | 0.1 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.0 | GO:0010624 | regulation of Schwann cell proliferation(GO:0010624) |
0.0 | 0.0 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
0.0 | 0.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.0 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.0 | 0.0 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.0 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.0 | 0.0 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.0 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.0 | 0.3 | GO:0000423 | macromitophagy(GO:0000423) |
0.0 | 0.0 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 0.1 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.0 | 0.2 | GO:0048240 | sperm capacitation(GO:0048240) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.0 | 0.0 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.0 | 0.0 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.0 | 0.0 | GO:0034502 | protein localization to chromosome(GO:0034502) protein localization to chromosome, telomeric region(GO:0070198) |
0.0 | 0.0 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.0 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.0 | 0.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.0 | 0.0 | GO:0034333 | adherens junction assembly(GO:0034333) |
0.0 | 0.0 | GO:0032095 | regulation of response to food(GO:0032095) |
0.0 | 0.0 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.0 | GO:0032094 | response to food(GO:0032094) |
0.0 | 0.0 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0060973 | cell migration involved in heart development(GO:0060973) |
0.0 | 0.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.0 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.3 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.0 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.0 | GO:0032769 | negative regulation of monooxygenase activity(GO:0032769) |
0.0 | 0.0 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.0 | GO:0044843 | cell cycle G1/S phase transition(GO:0044843) |
0.0 | 0.1 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.0 | 0.0 | GO:0051348 | negative regulation of transferase activity(GO:0051348) |
0.0 | 0.0 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0070723 | response to cholesterol(GO:0070723) |
0.0 | 0.0 | GO:0042048 | olfactory behavior(GO:0042048) |
0.0 | 0.0 | GO:0051917 | regulation of fibrinolysis(GO:0051917) |
0.0 | 0.0 | GO:1990089 | response to nerve growth factor(GO:1990089) cellular response to nerve growth factor stimulus(GO:1990090) |
0.0 | 0.0 | GO:0021529 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) |
0.0 | 0.0 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
0.0 | 0.0 | GO:0015791 | polyol transport(GO:0015791) |
0.0 | 0.0 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 17.2 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
5.1 | 20.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
4.6 | 23.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
4.4 | 17.8 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
4.4 | 30.7 | GO:0042382 | paraspeckles(GO:0042382) |
4.3 | 17.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
4.2 | 12.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
4.0 | 27.9 | GO:0070688 | MLL5-L complex(GO:0070688) |
3.5 | 52.8 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
3.5 | 13.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
3.2 | 16.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
3.1 | 12.3 | GO:0097452 | GAIT complex(GO:0097452) |
3.1 | 9.2 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
2.9 | 2.9 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
2.8 | 28.2 | GO:0034709 | methylosome(GO:0034709) |
2.8 | 8.3 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
2.8 | 88.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
2.7 | 10.6 | GO:0098536 | deuterosome(GO:0098536) |
2.5 | 15.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
2.5 | 44.1 | GO:0000242 | pericentriolar material(GO:0000242) |
2.4 | 7.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.4 | 9.7 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
2.3 | 7.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
2.3 | 25.4 | GO:0016580 | Sin3 complex(GO:0016580) |
2.3 | 11.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
2.2 | 15.7 | GO:0016272 | prefoldin complex(GO:0016272) |
2.2 | 6.7 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
2.2 | 23.7 | GO:0017119 | Golgi transport complex(GO:0017119) |
2.1 | 12.5 | GO:0031415 | NatA complex(GO:0031415) |
2.0 | 10.0 | GO:0000235 | astral microtubule(GO:0000235) |
2.0 | 18.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
2.0 | 5.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
1.9 | 13.2 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
1.7 | 5.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
1.7 | 6.6 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
1.6 | 8.2 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
1.6 | 6.5 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.6 | 6.5 | GO:0000805 | X chromosome(GO:0000805) |
1.6 | 3.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
1.6 | 9.3 | GO:0016589 | NURF complex(GO:0016589) |
1.6 | 7.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
1.5 | 21.7 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
1.5 | 6.2 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
1.5 | 11.7 | GO:0000124 | SAGA complex(GO:0000124) |
1.5 | 10.2 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
1.4 | 7.2 | GO:0000812 | Swr1 complex(GO:0000812) |
1.4 | 9.9 | GO:0030056 | hemidesmosome(GO:0030056) |
1.4 | 8.4 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
1.4 | 5.6 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
1.4 | 4.1 | GO:1903349 | omegasome membrane(GO:1903349) |
1.3 | 8.0 | GO:0000796 | condensin complex(GO:0000796) |
1.3 | 18.8 | GO:0071565 | nBAF complex(GO:0071565) |
1.3 | 5.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
1.3 | 16.0 | GO:0031011 | Ino80 complex(GO:0031011) |
1.3 | 9.3 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
1.3 | 5.3 | GO:0042825 | TAP complex(GO:0042825) |
1.3 | 46.2 | GO:0016592 | mediator complex(GO:0016592) |
1.3 | 51.0 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
1.2 | 7.5 | GO:0098553 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
1.2 | 7.4 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
1.2 | 14.5 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
1.2 | 2.4 | GO:0005687 | U4 snRNP(GO:0005687) |
1.2 | 3.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.1 | 4.5 | GO:0005955 | calcineurin complex(GO:0005955) |
1.1 | 20.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
1.1 | 1.1 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
1.1 | 13.1 | GO:0005685 | U1 snRNP(GO:0005685) |
1.1 | 3.3 | GO:0005642 | annulate lamellae(GO:0005642) |
1.1 | 4.3 | GO:0045298 | tubulin complex(GO:0045298) |
1.1 | 5.4 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
1.1 | 81.0 | GO:0016607 | nuclear speck(GO:0016607) |
1.0 | 11.4 | GO:0042555 | MCM complex(GO:0042555) |
1.0 | 11.0 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
1.0 | 5.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
1.0 | 6.7 | GO:0034385 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
1.0 | 2.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.9 | 0.9 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.9 | 10.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.9 | 11.1 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.9 | 7.3 | GO:0005682 | U5 snRNP(GO:0005682) |
0.9 | 11.0 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.9 | 2.7 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.9 | 1.8 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.9 | 5.4 | GO:0042405 | nuclear inclusion body(GO:0042405) |
0.9 | 6.2 | GO:0090543 | Flemming body(GO:0090543) |
0.9 | 6.2 | GO:0033263 | CORVET complex(GO:0033263) |
0.9 | 5.2 | GO:0034464 | BBSome(GO:0034464) |
0.9 | 3.5 | GO:0005667 | transcription factor complex(GO:0005667) |
0.8 | 14.4 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.8 | 7.6 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.8 | 10.0 | GO:0001891 | phagocytic cup(GO:0001891) |
0.8 | 8.3 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
0.8 | 1.7 | GO:0000243 | commitment complex(GO:0000243) |
0.8 | 10.8 | GO:0036038 | MKS complex(GO:0036038) |
0.8 | 7.4 | GO:0031932 | TORC2 complex(GO:0031932) |
0.8 | 13.8 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.8 | 6.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.8 | 16.6 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.8 | 11.8 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
0.8 | 2.4 | GO:0044393 | microspike(GO:0044393) |
0.8 | 6.3 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.8 | 11.8 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
0.8 | 6.2 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.8 | 2.3 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.8 | 8.4 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
0.8 | 4.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.8 | 6.8 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.8 | 4.5 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.7 | 5.2 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.7 | 2.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.7 | 15.0 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.7 | 32.8 | GO:0000502 | proteasome complex(GO:0000502) |
0.7 | 18.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.7 | 10.6 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.7 | 2.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.7 | 2.8 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.7 | 13.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.7 | 2.1 | GO:0071203 | WASH complex(GO:0071203) |
0.7 | 7.5 | GO:0035102 | PRC1 complex(GO:0035102) |
0.7 | 6.7 | GO:0008278 | cohesin complex(GO:0008278) |
0.7 | 48.4 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.7 | 2.7 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.7 | 3.9 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.6 | 1.9 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.6 | 12.3 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
0.6 | 7.7 | GO:0000791 | euchromatin(GO:0000791) |
0.6 | 9.3 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.6 | 21.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.6 | 67.6 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.6 | 1.8 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.6 | 4.8 | GO:0031512 | motile primary cilium(GO:0031512) |
0.6 | 4.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.6 | 28.0 | GO:0005871 | kinesin complex(GO:0005871) |
0.6 | 24.1 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.6 | 1.7 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
0.5 | 2.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.5 | 1.5 | GO:0035363 | histone locus body(GO:0035363) |
0.5 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
0.5 | 2.0 | GO:0044194 | cytolytic granule(GO:0044194) |
0.5 | 23.3 | GO:0032587 | ruffle membrane(GO:0032587) |
0.5 | 1.5 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
0.5 | 25.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.5 | 0.5 | GO:0098687 | chromosomal region(GO:0098687) |
0.5 | 1.9 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.5 | 1.9 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.5 | 3.3 | GO:0090544 | BAF-type complex(GO:0090544) |
0.5 | 1.4 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.4 | 9.9 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 3.1 | GO:0001939 | female pronucleus(GO:0001939) |
0.4 | 2.6 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.4 | 3.0 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.4 | 3.8 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.4 | 3.4 | GO:0045120 | pronucleus(GO:0045120) |
0.4 | 1.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.4 | 4.2 | GO:0031143 | pseudopodium(GO:0031143) |
0.4 | 2.1 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.4 | 17.2 | GO:0005795 | Golgi stack(GO:0005795) |
0.4 | 1.2 | GO:1990423 | RZZ complex(GO:1990423) |
0.4 | 15.6 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.4 | 5.6 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.4 | 4.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 25.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.4 | 4.7 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.4 | 1.2 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.4 | 29.4 | GO:0005840 | ribosome(GO:0005840) |
0.4 | 1.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.4 | 1.6 | GO:0000152 | nuclear ubiquitin ligase complex(GO:0000152) |
0.4 | 1.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.4 | 5.0 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.4 | 5.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.4 | 3.3 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.4 | 16.5 | GO:0016363 | nuclear matrix(GO:0016363) |
0.4 | 16.3 | GO:0016605 | PML body(GO:0016605) |
0.4 | 5.7 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.3 | 0.7 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.0 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.3 | 1.0 | GO:0010369 | chromocenter(GO:0010369) |
0.3 | 1.0 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.3 | 15.5 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.3 | 8.6 | GO:0072686 | mitotic spindle(GO:0072686) |
0.3 | 1.0 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.3 | 7.8 | GO:0035097 | histone methyltransferase complex(GO:0035097) |
0.3 | 7.1 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.3 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 62.4 | GO:0000785 | chromatin(GO:0000785) |
0.3 | 1.3 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.6 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.3 | 2.2 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 1.5 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 0.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 0.9 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.3 | 11.9 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.3 | 1.8 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.3 | 3.2 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.3 | 2.3 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.3 | 328.0 | GO:0005654 | nucleoplasm(GO:0005654) |
0.3 | 9.7 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.3 | 2.0 | GO:0090533 | cation-transporting ATPase complex(GO:0090533) |
0.3 | 3.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.3 | 7.0 | GO:0031941 | filamentous actin(GO:0031941) |
0.3 | 18.3 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 14.6 | GO:0030496 | midbody(GO:0030496) |
0.3 | 2.5 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.3 | 1.6 | GO:0005869 | dynactin complex(GO:0005869) |
0.3 | 0.3 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 9.6 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.3 | 0.8 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 2.6 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.3 | 1.3 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.3 | 3.3 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 2.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 40.1 | GO:0005635 | nuclear envelope(GO:0005635) |
0.2 | 0.5 | GO:0097451 | glial limiting end-foot(GO:0097451) |
0.2 | 2.4 | GO:0002102 | podosome(GO:0002102) |
0.2 | 4.5 | GO:0032040 | small-subunit processome(GO:0032040) |
0.2 | 1.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.2 | 8.8 | GO:0001726 | ruffle(GO:0001726) |
0.2 | 6.4 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.7 | GO:0042827 | platelet dense granule(GO:0042827) |
0.2 | 0.4 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 10.4 | GO:0042641 | actomyosin(GO:0042641) |
0.2 | 2.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 1.7 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 3.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.2 | 1.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.2 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.2 | 0.8 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.2 | 4.6 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.2 | 4.5 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 1.9 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 0.7 | GO:0043219 | lateral loop(GO:0043219) |
0.2 | 8.4 | GO:0005819 | spindle(GO:0005819) |
0.2 | 2.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.6 | GO:0042629 | mast cell granule(GO:0042629) |
0.2 | 39.3 | GO:0005730 | nucleolus(GO:0005730) |
0.2 | 2.7 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.2 | 0.2 | GO:1990393 | 3M complex(GO:1990393) |
0.2 | 5.4 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.2 | 2.0 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.2 | 2.7 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 155.3 | GO:0005739 | mitochondrion(GO:0005739) |
0.2 | 2.3 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.1 | 0.6 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.1 | 0.3 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.4 | GO:0044327 | dendritic spine head(GO:0044327) |
0.1 | 3.2 | GO:0005884 | actin filament(GO:0005884) |
0.1 | 1.0 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 0.4 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.1 | 0.1 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.1 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 1.3 | GO:0043034 | costamere(GO:0043034) |
0.1 | 4.6 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 1.3 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 3.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.2 | GO:0005914 | spot adherens junction(GO:0005914) |
0.1 | 4.9 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 1.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 0.4 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.1 | 0.7 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.6 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.1 | 0.6 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.1 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.1 | 1.4 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.3 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 0.5 | GO:0000801 | central element(GO:0000801) |
0.1 | 4.1 | GO:0030027 | lamellipodium(GO:0030027) |
0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
0.1 | 0.1 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.1 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 0.1 | GO:0030120 | vesicle coat(GO:0030120) |
0.1 | 0.1 | GO:0032437 | cuticular plate(GO:0032437) |
0.1 | 189.1 | GO:0005634 | nucleus(GO:0005634) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.2 | GO:0030897 | HOPS complex(GO:0030897) |
0.1 | 5.0 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.1 | 0.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 0.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 0.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.9 | GO:0032420 | stereocilium(GO:0032420) |
0.1 | 0.1 | GO:0044299 | C-fiber(GO:0044299) |
0.1 | 0.1 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.1 | 0.1 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 3.4 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.2 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.1 | 0.2 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:0044427 | chromosomal part(GO:0044427) |
0.0 | 0.0 | GO:1990357 | terminal web(GO:1990357) |
0.0 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.0 | 0.4 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.0 | 0.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.0 | 0.8 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.2 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.0 | 0.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 2.1 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.2 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 5.5 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.0 | 0.1 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 0.0 | GO:0031231 | intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 0.3 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 0.1 | GO:0031417 | NatC complex(GO:0031417) |
0.0 | 0.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.0 | 0.1 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.0 | 0.0 | GO:0031967 | organelle envelope(GO:0031967) |
0.0 | 0.1 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.0 | 0.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.0 | 0.0 | GO:0044216 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.0 | 0.4 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.0 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.0 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.2 | GO:0001527 | microfibril(GO:0001527) |
0.0 | 0.0 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.0 | 0.3 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.0 | 0.0 | GO:0097543 | ciliary inversin compartment(GO:0097543) |
0.0 | 0.0 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.0 | 0.0 | GO:0031527 | filopodium membrane(GO:0031527) |
0.0 | 0.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.0 | 0.0 | GO:0097450 | astrocyte end-foot(GO:0097450) |
0.0 | 0.1 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.0 | 0.0 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.0 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.0 | 0.0 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0005594 | collagen type IX trimer(GO:0005594) |
0.0 | 0.0 | GO:0097422 | tubular endosome(GO:0097422) |
0.0 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
6.8 | 34.0 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
5.4 | 27.2 | GO:0050815 | phosphoserine binding(GO:0050815) |
5.3 | 21.3 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
5.0 | 15.0 | GO:0016015 | morphogen activity(GO:0016015) |
4.9 | 19.4 | GO:0036033 | mediator complex binding(GO:0036033) |
3.8 | 34.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
3.8 | 15.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
3.7 | 14.9 | GO:1990715 | mRNA CDS binding(GO:1990715) |
3.5 | 13.8 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
3.4 | 20.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
3.4 | 20.4 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
3.2 | 16.0 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
3.1 | 12.3 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
3.1 | 15.3 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
3.1 | 15.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
3.0 | 11.8 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
2.9 | 17.7 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
2.9 | 11.5 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
2.9 | 25.7 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
2.8 | 8.3 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
2.8 | 11.0 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
2.8 | 2.8 | GO:1990188 | euchromatin binding(GO:1990188) |
2.7 | 40.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
2.7 | 13.3 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
2.6 | 13.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
2.6 | 7.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
2.5 | 7.5 | GO:0008412 | 4-hydroxybenzoate octaprenyltransferase activity(GO:0008412) protoheme IX farnesyltransferase activity(GO:0008495) (S)-2,3-di-O-geranylgeranylglyceryl phosphate synthase activity(GO:0043888) cadaverine aminopropyltransferase activity(GO:0043918) agmatine aminopropyltransferase activity(GO:0043919) 1,4-dihydroxy-2-naphthoate octaprenyltransferase activity(GO:0046428) trans-pentaprenyltranstransferase activity(GO:0048045) ATP dimethylallyltransferase activity(GO:0052622) ADP dimethylallyltransferase activity(GO:0052623) |
2.5 | 29.6 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
2.4 | 45.8 | GO:0003746 | translation elongation factor activity(GO:0003746) |
2.3 | 6.9 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
2.3 | 6.8 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.3 | 38.6 | GO:0036002 | pre-mRNA binding(GO:0036002) |
2.3 | 6.8 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
2.2 | 11.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
2.2 | 13.0 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
2.1 | 14.8 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.1 | 10.5 | GO:0070728 | leucine binding(GO:0070728) |
2.1 | 10.5 | GO:0043426 | MRF binding(GO:0043426) |
2.1 | 31.2 | GO:0008143 | poly(A) binding(GO:0008143) |
2.1 | 8.3 | GO:0097001 | ceramide binding(GO:0097001) |
2.1 | 8.3 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
2.1 | 10.3 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
1.9 | 33.0 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
1.9 | 7.7 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
1.9 | 11.6 | GO:0015288 | porin activity(GO:0015288) |
1.9 | 7.5 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
1.9 | 9.4 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
1.8 | 5.5 | GO:0005119 | smoothened binding(GO:0005119) |
1.8 | 10.9 | GO:0031419 | cobalamin binding(GO:0031419) |
1.8 | 5.3 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
1.8 | 8.8 | GO:1990239 | steroid hormone binding(GO:1990239) |
1.8 | 28.0 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
1.8 | 1.8 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
1.7 | 5.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
1.7 | 1.7 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
1.7 | 5.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
1.7 | 61.4 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
1.7 | 5.1 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
1.7 | 5.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
1.7 | 5.0 | GO:0016509 | long-chain-3-hydroxyacyl-CoA dehydrogenase activity(GO:0016509) |
1.6 | 9.7 | GO:0050733 | RS domain binding(GO:0050733) |
1.6 | 4.8 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
1.6 | 12.5 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
1.5 | 7.7 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
1.5 | 12.2 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
1.5 | 13.2 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
1.5 | 5.8 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
1.5 | 2.9 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
1.4 | 4.3 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
1.4 | 1.4 | GO:0010861 | thyroid hormone receptor activator activity(GO:0010861) |
1.4 | 11.4 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
1.4 | 5.7 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
1.4 | 23.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
1.3 | 5.3 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
1.3 | 7.6 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
1.3 | 3.8 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.2 | 15.9 | GO:0044769 | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism(GO:0044769) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.2 | 12.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
1.2 | 4.8 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.2 | 5.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.2 | 7.1 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
1.2 | 3.5 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
1.2 | 8.1 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
1.2 | 2.3 | GO:0070840 | dynein complex binding(GO:0070840) |
1.2 | 4.6 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
1.2 | 18.5 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
1.1 | 4.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
1.1 | 6.8 | GO:0008199 | ferric iron binding(GO:0008199) |
1.1 | 11.9 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
1.1 | 9.7 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
1.1 | 4.3 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
1.1 | 37.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
1.1 | 8.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
1.0 | 11.4 | GO:0035497 | cAMP response element binding(GO:0035497) |
1.0 | 8.3 | GO:0001098 | basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
1.0 | 24.6 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
1.0 | 13.2 | GO:0017160 | Ral GTPase binding(GO:0017160) |
1.0 | 16.2 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
1.0 | 17.2 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
1.0 | 21.0 | GO:0018602 | sulfonate dioxygenase activity(GO:0000907) 2,4-dichlorophenoxyacetate alpha-ketoglutarate dioxygenase activity(GO:0018602) hypophosphite dioxygenase activity(GO:0034792) gibberellin 2-beta-dioxygenase activity(GO:0045543) C-19 gibberellin 2-beta-dioxygenase activity(GO:0052634) C-20 gibberellin 2-beta-dioxygenase activity(GO:0052635) |
0.9 | 0.9 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.9 | 9.2 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.9 | 1.8 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
0.9 | 2.7 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.9 | 3.6 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 29.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.9 | 12.2 | GO:0001618 | virus receptor activity(GO:0001618) |
0.9 | 23.4 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.9 | 2.6 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.8 | 21.8 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.8 | 7.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.8 | 17.3 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.8 | 2.4 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.8 | 1.6 | GO:0030519 | snoRNP binding(GO:0030519) |
0.8 | 2.4 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.8 | 14.3 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.8 | 23.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.8 | 2.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.8 | 29.3 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.8 | 6.9 | GO:0031996 | thioesterase binding(GO:0031996) |
0.8 | 4.6 | GO:0035473 | lipase binding(GO:0035473) |
0.8 | 9.1 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.8 | 33.3 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.8 | 6.0 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.7 | 16.8 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.7 | 2.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
0.7 | 2.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.7 | 4.3 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.7 | 4.3 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.7 | 18.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.7 | 4.2 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 6.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.7 | 2.7 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.7 | 2.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 21.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.7 | 9.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.7 | 2.6 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 7.1 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.6 | 10.0 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.6 | 6.8 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.6 | 0.6 | GO:0052744 | phosphatidylinositol monophosphate phosphatase activity(GO:0052744) |
0.6 | 1.8 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.6 | 10.3 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.6 | 16.3 | GO:0052771 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.6 | 3.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.6 | 12.0 | GO:0045309 | protein phosphorylated amino acid binding(GO:0045309) |
0.6 | 4.2 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.6 | 0.6 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.6 | 22.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.6 | 13.7 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.6 | 4.0 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 2.8 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.6 | 5.6 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.6 | 1.7 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.6 | 3.4 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.6 | 7.8 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 2.8 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.6 | 23.9 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 12.7 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.5 | 1.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.5 | 1.6 | GO:0071253 | connexin binding(GO:0071253) |
0.5 | 0.5 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.5 | 3.2 | GO:0016937 | short-branched-chain-acyl-CoA dehydrogenase activity(GO:0016937) |
0.5 | 5.3 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.5 | 15.9 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.5 | 16.9 | GO:0000049 | tRNA binding(GO:0000049) |
0.5 | 4.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.5 | 9.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.5 | 7.3 | GO:0031489 | myosin V binding(GO:0031489) |
0.5 | 2.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.5 | 17.5 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.5 | 2.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.5 | 1.5 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.5 | 2.5 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.5 | 50.8 | GO:0003729 | mRNA binding(GO:0003729) |
0.5 | 1.4 | GO:2001069 | glycogen binding(GO:2001069) |
0.5 | 2.9 | GO:0031685 | adenosine receptor binding(GO:0031685) |
0.5 | 1.9 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.5 | 1.4 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.5 | 2.3 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.5 | 8.4 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.5 | 1.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 3.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.4 | 3.0 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.4 | 3.0 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.4 | 1.7 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.4 | 8.8 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.4 | 15.4 | GO:0004527 | exonuclease activity(GO:0004527) |
0.4 | 5.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 1.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.4 | 2.0 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.4 | 2.0 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.4 | 2.8 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.4 | 5.1 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 2.8 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 12.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.4 | 3.9 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 65.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.4 | 1.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.4 | 1.5 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.4 | 2.6 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.4 | 1.9 | GO:0046790 | virion binding(GO:0046790) |
0.4 | 1.9 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
0.4 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.4 | 3.2 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.4 | 25.0 | GO:0047485 | protein N-terminus binding(GO:0047485) |
0.4 | 4.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.4 | 6.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.3 | 229.3 | GO:0044822 | poly(A) RNA binding(GO:0044822) |
0.3 | 4.7 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.3 | 2.0 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 4.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.3 | 31.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.3 | 2.3 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.3 | 4.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.3 | 0.3 | GO:0008142 | oxysterol binding(GO:0008142) |
0.3 | 3.8 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.3 | 5.7 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.3 | 0.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.3 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.3 | 3.6 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.3 | 0.9 | GO:0034950 | mono-butyltin dioxygenase activity(GO:0018586) tri-n-butyltin dioxygenase activity(GO:0018588) di-n-butyltin dioxygenase activity(GO:0018589) methylsilanetriol hydroxylase activity(GO:0018590) methyl tertiary butyl ether 3-monooxygenase activity(GO:0018591) 4-nitrocatechol 4-monooxygenase activity(GO:0018592) 4-chlorophenoxyacetate monooxygenase activity(GO:0018593) tert-butanol 2-monooxygenase activity(GO:0018594) alpha-pinene monooxygenase activity(GO:0018595) dimethylsilanediol hydroxylase activity(GO:0018596) ammonia monooxygenase activity(GO:0018597) hydroxymethylsilanetriol oxidase activity(GO:0018598) 2-hydroxyisobutyrate 3-monooxygenase activity(GO:0018599) alpha-pinene dehydrogenase activity(GO:0018600) bisphenol A hydroxylase B activity(GO:0034559) 2,2-bis(4-hydroxyphenyl)-1-propanol hydroxylase activity(GO:0034562) 9-fluorenone-3,4-dioxygenase activity(GO:0034786) anthracene 9,10-dioxygenase activity(GO:0034816) 2-(methylthio)benzothiazole monooxygenase activity(GO:0034857) 2-hydroxybenzothiazole monooxygenase activity(GO:0034858) benzothiazole monooxygenase activity(GO:0034859) 2,6-dihydroxybenzothiazole monooxygenase activity(GO:0034862) pinacolone 5-monooxygenase activity(GO:0034870) thioacetamide S-oxygenase activity(GO:0034873) thioacetamide S-oxide S-oxygenase activity(GO:0034874) endosulfan monooxygenase I activity(GO:0034888) N-nitrodimethylamine hydroxylase activity(GO:0034893) 4-(1-ethyl-1,4-dimethyl-pentyl)phenol monoxygenase activity(GO:0034897) endosulfan ether monooxygenase activity(GO:0034903) pyrene 4,5-monooxygenase activity(GO:0034925) pyrene 1,2-monooxygenase activity(GO:0034927) 1-hydroxypyrene 6,7-monooxygenase activity(GO:0034928) 1-hydroxypyrene 7,8-monooxygenase activity(GO:0034929) phenylboronic acid monooxygenase activity(GO:0034950) spheroidene monooxygenase activity(GO:0043823) |
0.3 | 15.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.3 | 9.9 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
0.3 | 12.5 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.3 | 3.4 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.3 | 2.3 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.3 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.3 | 36.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.3 | 1.7 | GO:0031386 | protein tag(GO:0031386) |
0.3 | 4.3 | GO:0043022 | ribosome binding(GO:0043022) |
0.3 | 1.1 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.3 | 2.4 | GO:0015254 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.3 | 2.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 3.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.3 | 2.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.3 | 3.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.8 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.3 | 4.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 3.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.2 | 8.9 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 3.5 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.2 | 1.5 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
0.2 | 2.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.2 | 39.5 | GO:0043774 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 1.7 | GO:0044548 | S100 protein binding(GO:0044548) |
0.2 | 0.7 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 4.0 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.2 | 22.8 | GO:0004518 | nuclease activity(GO:0004518) |
0.2 | 0.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.2 | 67.2 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
0.2 | 0.9 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.2 | 7.1 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.2 | 0.9 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.2 | 0.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.2 | 7.5 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.2 | 0.2 | GO:0034212 | peptide N-acetyltransferase activity(GO:0034212) |
0.2 | 0.4 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.2 | 2.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 7.0 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.2 | 22.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.2 | 8.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.2 | 2.3 | GO:0052890 | acyl-CoA dehydrogenase activity(GO:0003995) oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.2 | 2.1 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.0 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.2 | 11.8 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.2 | 2.0 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.2 | 1.0 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.2 | 1.8 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.2 | 0.8 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.2 | 1.2 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.2 | 1.5 | GO:0039706 | co-receptor binding(GO:0039706) |
0.2 | 1.1 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.2 | 0.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
0.2 | 8.4 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.2 | 1.3 | GO:0036442 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) hydrogen-exporting ATPase activity(GO:0036442) |
0.2 | 0.4 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.2 | 0.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 2.7 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.2 | 0.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 4.0 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 5.3 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.2 | 0.3 | GO:0003916 | DNA topoisomerase activity(GO:0003916) DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.2 | 1.5 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.2 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.5 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.2 | 1.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.2 | 29.8 | GO:0003682 | chromatin binding(GO:0003682) |
0.2 | 0.5 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.3 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.1 | 25.9 | GO:0003723 | RNA binding(GO:0003723) |
0.1 | 0.7 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 1.2 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.1 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 0.3 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.1 | 2.1 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 1.7 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 1.0 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.7 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 1.5 | GO:0052773 | protein-N-terminal asparagine amidohydrolase activity(GO:0008418) UDP-3-O-[3-hydroxymyristoyl] N-acetylglucosamine deacetylase activity(GO:0008759) iprodione amidohydrolase activity(GO:0018748) (3,5-dichlorophenylurea)acetate amidohydrolase activity(GO:0018749) 4'-(2-hydroxyisopropyl)phenylurea amidohydrolase activity(GO:0034571) didemethylisoproturon amidohydrolase activity(GO:0034573) N-isopropylacetanilide amidohydrolase activity(GO:0034576) N-cyclohexylformamide amidohydrolase activity(GO:0034781) isonicotinic acid hydrazide hydrolase activity(GO:0034876) cis-aconitamide amidase activity(GO:0034882) gamma-N-formylaminovinylacetate hydrolase activity(GO:0034885) N2-acetyl-L-lysine deacetylase activity(GO:0043747) O-succinylbenzoate synthase activity(GO:0043748) indoleacetamide hydrolase activity(GO:0043864) N-acetylcitrulline deacetylase activity(GO:0043909) N-acetylgalactosamine-6-phosphate deacetylase activity(GO:0047419) diacetylchitobiose deacetylase activity(GO:0052773) chitooligosaccharide deacetylase activity(GO:0052790) |
0.1 | 1.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.1 | 3.8 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.1 | 0.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
0.1 | 2.7 | GO:0019902 | phosphatase binding(GO:0019902) |
0.1 | 1.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.2 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.1 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 0.9 | GO:0034062 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.1 | 0.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.4 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.1 | 3.2 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 3.2 | GO:0043738 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) epoxyqueuosine reductase activity(GO:0052693) |
0.1 | 0.6 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.1 | 0.3 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 0.4 | GO:0052795 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 0.9 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.7 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.1 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.5 | GO:0042393 | histone binding(GO:0042393) |
0.1 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.1 | 0.2 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.1 | 3.7 | GO:0004386 | helicase activity(GO:0004386) |
0.1 | 1.0 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.4 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 1.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 0.6 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.0 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 0.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.1 | 1.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.1 | 0.4 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 11.0 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
0.1 | 1.0 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 1.1 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 0.3 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.4 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.3 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.1 | 1.7 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 2.3 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.1 | 13.9 | GO:0016758 | transferase activity, transferring hexosyl groups(GO:0016758) |
0.1 | 0.2 | GO:0035939 | satellite DNA binding(GO:0003696) microsatellite binding(GO:0035939) |
0.1 | 0.2 | GO:0046625 | sphingolipid binding(GO:0046625) |
0.1 | 0.3 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.8 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 0.7 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 1.9 | GO:0015923 | mannosidase activity(GO:0015923) |
0.1 | 0.2 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.1 | 0.7 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.1 | 0.2 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 0.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 75.2 | GO:0003677 | DNA binding(GO:0003677) |
0.1 | 0.2 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.1 | GO:0043199 | sulfate binding(GO:0043199) |
0.1 | 0.1 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.1 | 0.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.1 | 0.4 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 1.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.1 | 0.6 | GO:0019213 | deacetylase activity(GO:0019213) |
0.1 | 1.6 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 0.1 | GO:0043125 | ErbB-3 class receptor binding(GO:0043125) |
0.1 | 0.2 | GO:0008252 | nucleotidase activity(GO:0008252) |
0.1 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.1 | 0.6 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.1 | 0.1 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.1 | 0.3 | GO:0030250 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.1 | 0.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0019002 | GMP binding(GO:0019002) |
0.1 | 2.0 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.1 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.5 | GO:0031005 | filamin binding(GO:0031005) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.1 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.1 | 3.7 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.4 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.1 | 1.6 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.1 | 0.4 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.5 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 2.7 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 0.5 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.2 | GO:0019976 | interleukin-2 binding(GO:0019976) |
0.1 | 0.3 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.1 | 0.1 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.2 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.1 | 5.0 | GO:0046906 | tetrapyrrole binding(GO:0046906) |
0.1 | 9.3 | GO:0008236 | serine-type peptidase activity(GO:0008236) serine hydrolase activity(GO:0017171) |
0.1 | 3.9 | GO:0004721 | phosphoprotein phosphatase activity(GO:0004721) |
0.1 | 0.1 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.1 | 0.2 | GO:0034596 | phosphatidylinositol phosphate 4-phosphatase activity(GO:0034596) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.0 | 0.3 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.0 | 0.1 | GO:0042731 | PH domain binding(GO:0042731) |
0.0 | 0.1 | GO:0038132 | neuregulin binding(GO:0038132) |
0.0 | 0.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.0 | GO:0015927 | trehalase activity(GO:0015927) |
0.0 | 0.1 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.0 | 0.2 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.0 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.0 | 0.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
0.0 | 0.1 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.0 | 0.1 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.0 | 0.1 | GO:0008808 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.0 | 0.1 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.0 | 0.2 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.0 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.0 | 0.1 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.0 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.0 | 0.0 | GO:0034618 | arginine binding(GO:0034618) |
0.0 | 0.0 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.1 | GO:0022858 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.0 | 0.0 | GO:0051373 | FATZ binding(GO:0051373) |
0.0 | 0.1 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
0.0 | 0.6 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.2 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.0 | GO:0070905 | serine binding(GO:0070905) |
0.0 | 0.1 | GO:0016653 | oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.0 | 0.1 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.1 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.0 | 0.0 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.0 | 0.0 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.0 | 0.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.0 | 0.1 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) tRNA guanylyltransferase activity(GO:0008193) |
0.0 | 0.0 | GO:0031559 | oxidosqualene cyclase activity(GO:0031559) |
0.0 | 0.1 | GO:0051380 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
0.0 | 0.1 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.0 | 0.2 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 3.1 | GO:0016887 | ATPase activity(GO:0016887) |
0.0 | 0.0 | GO:0043733 | alkylbase DNA N-glycosylase activity(GO:0003905) DNA-3-methylbase glycosylase activity(GO:0043733) |
0.0 | 0.0 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
0.0 | 0.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.9 | GO:0016791 | phosphatase activity(GO:0016791) |
0.0 | 0.1 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.0 | 0.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.0 | 0.4 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.1 | GO:0004601 | peroxidase activity(GO:0004601) oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.0 | GO:0051765 | inositol tetrakisphosphate kinase activity(GO:0051765) |
0.0 | 0.1 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.2 | GO:0015149 | hexose transmembrane transporter activity(GO:0015149) |
0.0 | 0.0 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.0 | 0.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.0 | 0.0 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.0 | 0.9 | GO:0019199 | transmembrane receptor protein kinase activity(GO:0019199) |
0.0 | 0.2 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.0 | 0.2 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.1 | GO:1902936 | phosphatidylinositol bisphosphate binding(GO:1902936) |
0.0 | 0.0 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.0 | 0.0 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.0 | 0.0 | GO:0004713 | protein tyrosine kinase activity(GO:0004713) |
0.0 | 0.1 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.0 | 0.0 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 0.7 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
0.0 | 0.0 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.0 | 0.5 | GO:0004672 | protein kinase activity(GO:0004672) |
0.0 | 0.0 | GO:0032190 | acrosin binding(GO:0032190) |
0.0 | 0.0 | GO:0008194 | UDP-glycosyltransferase activity(GO:0008194) |
0.0 | 0.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.0 | 0.2 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.6 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.0 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.0 | 0.1 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.0 | 0.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.0 | 0.1 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0042805 | actinin binding(GO:0042805) |
0.0 | 0.1 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.0 | 0.0 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 2.2 | GO:0019900 | kinase binding(GO:0019900) |
0.0 | 0.0 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.0 | 0.1 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.0 | 0.1 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.1 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.3 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.0 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.0 | 0.1 | GO:0016595 | glutamate binding(GO:0016595) |
0.0 | 0.5 | GO:0003712 | transcription cofactor activity(GO:0003712) |
0.0 | 0.0 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.0 | 0.2 | GO:0030276 | clathrin binding(GO:0030276) |
0.0 | 0.0 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.0 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.0 | 0.0 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 0.0 | GO:0019825 | oxygen binding(GO:0019825) |
0.0 | 0.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.0 | 0.0 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.0 | 0.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.0 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.0 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.0 | 0.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.0 | 0.5 | GO:0005516 | calmodulin binding(GO:0005516) |
0.0 | 0.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.0 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.0 | 0.0 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.0 | 0.0 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.1 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.0 | 2.1 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.0 | GO:0015643 | toxic substance binding(GO:0015643) |
0.0 | 0.0 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
0.0 | 0.0 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.0 | 0.0 | GO:0018561 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.0 | 0.0 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) pyrimidine nucleobase transmembrane transporter activity(GO:0005350) nucleobase transmembrane transporter activity(GO:0015205) |
0.0 | 0.1 | GO:0010181 | FMN binding(GO:0010181) |
0.0 | 0.0 | GO:0060090 | binding, bridging(GO:0060090) |
0.0 | 0.1 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.0 | 0.7 | GO:0015103 | inorganic anion transmembrane transporter activity(GO:0015103) |
0.0 | 0.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0072349 | modified amino acid transmembrane transporter activity(GO:0072349) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.0 | 0.0 | GO:0004937 | alpha1-adrenergic receptor activity(GO:0004937) |
0.0 | 0.1 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.2 | GO:0015297 | antiporter activity(GO:0015297) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.1 | 58.0 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
1.7 | 23.9 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
1.7 | 26.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
1.7 | 13.2 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.5 | 21.4 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
1.3 | 34.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
1.2 | 52.4 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
1.0 | 38.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.9 | 35.6 | PID LKB1 PATHWAY | LKB1 signaling events |
0.8 | 24.4 | PID FOXO PATHWAY | FoxO family signaling |
0.8 | 33.8 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.7 | 19.4 | PID BARD1 PATHWAY | BARD1 signaling events |
0.6 | 59.9 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.6 | 30.2 | PID P73PATHWAY | p73 transcription factor network |
0.6 | 9.2 | PID ATM PATHWAY | ATM pathway |
0.6 | 19.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.6 | 18.2 | PID E2F PATHWAY | E2F transcription factor network |
0.5 | 15.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.5 | 15.4 | PID PLK1 PATHWAY | PLK1 signaling events |
0.5 | 2.5 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.5 | 8.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.5 | 8.1 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.5 | 5.7 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 7.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.5 | 5.4 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 6.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.4 | 0.4 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 17.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.4 | 4.6 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 13.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.4 | 6.9 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.4 | 6.2 | PID INSULIN PATHWAY | Insulin Pathway |
0.4 | 10.0 | PID CDC42 PATHWAY | CDC42 signaling events |
0.4 | 5.3 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.3 | 6.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.3 | 1.6 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.3 | 6.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.3 | 7.7 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.3 | 6.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.3 | 4.7 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.3 | 5.5 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.3 | 2.7 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 2.0 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 9.0 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.3 | 12.3 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.3 | 3.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.3 | 8.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.3 | 3.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.3 | 7.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 9.2 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.2 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 4.5 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.4 | PID P53 REGULATION PATHWAY | p53 pathway |
0.2 | 2.8 | PID ATR PATHWAY | ATR signaling pathway |
0.2 | 2.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.2 | 0.6 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.2 | 1.8 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.2 | 0.2 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.2 | 3.0 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.2 | 1.1 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.2 | 0.7 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.2 | 3.1 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 3.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 6.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.1 | 4.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.4 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 2.0 | PID RAS PATHWAY | Regulation of Ras family activation |
0.1 | 1.8 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.1 | 3.7 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.2 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.1 | 1.6 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 1.4 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.5 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.1 | 1.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.5 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 0.1 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.8 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.4 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.1 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.1 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.4 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.1 | 1.1 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.4 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 0.4 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.0 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.8 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.5 | NABA COLLAGENS | Genes encoding collagen proteins |
0.0 | 0.1 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.0 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.2 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.0 | 0.0 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 0.1 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.0 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.4 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.2 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
0.0 | 0.1 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 0.2 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.2 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.2 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.3 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 0.1 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.1 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.0 | 2.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.0 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.1 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 17.9 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
2.2 | 37.7 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
2.0 | 20.3 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.9 | 31.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
1.7 | 90.8 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
1.6 | 6.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
1.6 | 23.3 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
1.5 | 21.7 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
1.5 | 23.5 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
1.5 | 21.8 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.3 | 17.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
1.3 | 19.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
1.3 | 14.0 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.2 | 13.5 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
1.2 | 17.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.2 | 2.4 | REACTOME SIGNALLING TO P38 VIA RIT AND RIN | Genes involved in Signalling to p38 via RIT and RIN |
1.2 | 15.4 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
1.2 | 7.0 | REACTOME REGULATION OF AMPK ACTIVITY VIA LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
1.2 | 23.2 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
1.1 | 23.9 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
1.1 | 34.9 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
1.0 | 10.1 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
1.0 | 8.0 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.9 | 26.4 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.9 | 2.8 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.9 | 6.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.9 | 23.2 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.9 | 7.9 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.9 | 11.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.9 | 14.6 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.9 | 16.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.8 | 4.9 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.8 | 17.1 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.8 | 36.6 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.8 | 44.7 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.8 | 20.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.8 | 9.1 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 10.9 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.7 | 10.8 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.7 | 8.5 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.7 | 1.4 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.7 | 27.4 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.7 | 3.4 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.7 | 5.9 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.6 | 3.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.6 | 56.3 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.6 | 31.5 | REACTOME TRANSLATION | Genes involved in Translation |
0.6 | 6.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 9.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.6 | 11.2 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.6 | 9.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 3.5 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.6 | 12.2 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.6 | 6.4 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.6 | 9.4 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.6 | 27.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.5 | 4.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.5 | 6.4 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 0.5 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.5 | 1.6 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 12.2 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.5 | 5.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.5 | 16.8 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.5 | 2.4 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.5 | 2.8 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.5 | 10.4 | REACTOME KINESINS | Genes involved in Kinesins |
0.5 | 20.8 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.5 | 54.4 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.5 | 2.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.4 | 2.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.4 | 7.5 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.4 | 11.9 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.4 | 8.3 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.4 | 8.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.4 | 4.6 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.4 | 0.8 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.4 | 4.1 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.4 | 1.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.4 | 7.4 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 0.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.4 | 8.7 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.4 | 15.7 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.4 | 9.4 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.3 | 0.3 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.3 | 8.2 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.3 | 0.3 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
0.3 | 2.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.3 | 8.2 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.3 | 3.3 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 2.0 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 2.5 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.3 | 1.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.3 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.3 | 2.9 | REACTOME METABOLISM OF RNA | Genes involved in Metabolism of RNA |
0.3 | 4.1 | REACTOME PLC BETA MEDIATED EVENTS | Genes involved in PLC beta mediated events |
0.3 | 11.2 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.2 | 1.9 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.2 | 2.2 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.2 | 2.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.2 | 5.0 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.2 | REACTOME CD28 CO STIMULATION | Genes involved in CD28 co-stimulation |
0.2 | 2.1 | REACTOME RNA POL I TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
0.2 | 0.7 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.2 | 2.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 10.3 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.2 | 5.5 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.2 | 5.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.2 | 1.4 | REACTOME RECRUITMENT OF MITOTIC CENTROSOME PROTEINS AND COMPLEXES | Genes involved in Recruitment of mitotic centrosome proteins and complexes |
0.2 | 0.4 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.2 | 2.9 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.2 | 12.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.2 | 1.3 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 2.0 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.2 | 0.4 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 1.5 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.2 | 2.9 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.2 | 1.2 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.2 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.2 | 2.1 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 2.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.1 | 2.9 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.1 | 3.5 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 3.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 1.1 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.2 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.1 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 0.7 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 1.0 | REACTOME ANTIGEN PROCESSING CROSS PRESENTATION | Genes involved in Antigen processing-Cross presentation |
0.1 | 0.5 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 10.1 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.6 | REACTOME PROTEIN FOLDING | Genes involved in Protein folding |
0.1 | 2.8 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.1 | 5.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 0.9 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.1 | 3.0 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 1.1 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 0.1 | REACTOME CIRCADIAN CLOCK | Genes involved in Circadian Clock |
0.1 | 0.5 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.1 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 1.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.1 | 0.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.4 | REACTOME REGULATED PROTEOLYSIS OF P75NTR | Genes involved in Regulated proteolysis of p75NTR |
0.1 | 0.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.1 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.1 | 0.1 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 0.4 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 0.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.4 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.0 | 0.2 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.7 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.3 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.0 | 0.1 | REACTOME P75NTR SIGNALS VIA NFKB | Genes involved in p75NTR signals via NF-kB |
0.0 | 0.3 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.0 | 0.1 | REACTOME SHC RELATED EVENTS | Genes involved in SHC-related events |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.4 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 0.8 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.0 | 0.2 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.0 | 0.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.3 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.2 | REACTOME TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER | Genes involved in Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer |
0.0 | 0.1 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.0 | 0.1 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 0.2 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.0 | 0.3 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.1 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.5 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.0 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.0 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.0 | 0.4 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.1 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.2 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 0.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.0 | 0.0 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.0 | 0.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.1 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.0 | 0.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.1 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |